



Exploring modalities in short and long term
2021
Thesis for the degree of Philosophiae Doctor (PhD)
University of Bergen, Norway
 
 
Treatment of Exercise-induced  
Laryngeal Obstruction 









Avhandling for graden philosophiae doctor (ph.d.) 





The work presented in this thesis was carried out between 2011 and 2020 and is based on 
patients referred for work-up and treatment at a dedicated respiratory outpatient clinic at 
Haukeland University Hospital Bergen, Norway, consisting of a cross-professional 
collaboration between Department of Pediatrics and Otolaryngology.  
 
The clinical work with EILO patients was started by my supervisors, and I was invited into 
this research environment as a medical student in 2010. This was at the very beginning of the 
systematically work in the “embryonic field” of developing treatment modalities for EILO. 
Research performed in a clinical setting, focusing on a condition that was poorly described, 
has certainly been challenging and sometimes “frustrating”, and has led to some limitations. 
The work has been gradually adjusted as our empirical understanding has developed. 
During my work with this thesis, the research environment has established itself as the Bergen 
ILO Research Group at Haukeland University Hospital.  
The supervisors during this work: 
Ola Drange Røksund, professor, main supervisor 
Thomas Halvorsen, professor 
John-Helge Heimdal, professor 
Hege Havstad Clemm, MD, PhD 
Tiina Andersen, MSc, PhD 
Statistical analysis was carried out under the supervision of Geir Egil Eide, Professor at 
Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway 
I was enrolled as a PhD student at the Department of Clinical Science, Faculty of Medicine 
and Dentistry, University of Bergen, Norway. Innlandet Hospital Trust, Department of 
Medicine, Gjøvik, Norway, funded the Phd fellowship from June 2018 to May 2020.  
 
Abbreviations 
CI:   Confidence interval 
CLE test:  Continuous laryngoscopy exercise test 
CLM:  Congenital laryngomalacia 
EIA:   Exercise induced asthma 
EIB:   Exercise induced bronchoconstriction  
EIIS:   Exercise induced inspiratory symptoms 
EILO:   Exercise induced laryngeal obstruction 
EILO-BI: (The Olin) Exercise induced laryngeal obstruction biphasic inspiration 
ELS:  European laryngological society 
ERS:  European respiratory society 
FEV1:   Forced expiratory volume in first second 
FIV1:   Forced inspiratory volume in first second 
FVL:   Flow volume loop 
GERD:  Gastro esophageal reflux disease 
IBA:  Information and breathing advice 
IMT:   Inspiratory muscle training 
IMET:   Inspiratory muscle endurance training 
IMST:   Inspiratory muscle strength training 
LCT:   Laryngeal control therapy 
PCA-muscle:  Posterior cricoarytenoid muscle 
Pimax:   Maximal inspiratory mouth pressure 
RV:   Residual volume 
SD:   Standard deviation  
TLC:   Total lung capacity 
TLE:   Therapeutic laryngoscopy during exercise  




First of all, I want to thank all patients, their guardians and the medical students who 
participated in the included studies. Without your contribution, none of this work would have 
been possible.  
I am forever grateful for the opportunity to be working with the ILO Research group and there 
are many people to thank for this experience being both educational and fun! 
My main supervisor, Ola Drange Røksund, the sole reason for engaging me to research and 
my big inspiration. From the first time we talked about the larynx in 2009, to almost daily 
talks the last year; you have always been available, supported me and thought me everything I 
know about EILO and a lot about life in general. Our discussions, your feedback and 
enthusiasm has made me want to spend a lot of my spear time working with EILO. Thank 
you! I look forward to the continued work, there is so much more we need to investigate…  
Another major strength Professor Røksund has is the ability to network, and always focus on 
collaboration, which has led me to be fortunate to work with many talented people;  
Professor Thomas Halvorsen, your knowledge, scientific writing, honest feedback combined 
with your humor has been indispensable. I am incredibly grateful to have worked with you 
and I have learned so much from you.  
Professor John-Helge Heimdal, your support of this work and your knowledge about the 
larynx has been an enormous inspiration and a great privilege. I appreciate your timely 
precision throughout this work.  
Associate professor Hege Havstad Clemm, thank you for valuable comments and support, for 
keeping order in all applications and approvals and for making possibilities happen in this 
research field. Our discussions on EILO has been much appreciated.   
Associate professor Tiina Andersen, I am incredibly thankful for all your knowledge, 
enthusiasm, humor and valuable comments and also for wanting to collaborate with “just a 
medical student” in 2010. I value our discussions, both educational and social.  
There are many more that deserves to be thanked; professor Trond Markestad for valuable 
support. Maria Vollsæter, for your appreciated comments and thorough proof-reading, and for 
talks about the important things in life. Magnus Hilland, for our collaboration, your humor, 
and valuable comments. Thor-Andre Ellingsen for always answering “yes” and for help with 
pictures, films and editing. Also, the rest of the team; Lorentz Sandvik, Ingvild Engesæter, 
Mette Engan, Ida Jansrud Hammer, Merete Engeseth, Merete Benestad Tom Karlsen and Zoë 
Fretheim-Kelly.  
Professor Geir-Egil Eide, thank you for help with overlooking the statistical analysis, for 
patience and helping me to understand basic statistics.  
For personal reasons I moved to the other side; Gjøvik. Thanks to Innlandet Hospital Trust for 
funding the last period of this work and to my boss, Anne Fagerheim Skaug for being positive 
and facilitating leave of absence. Moreover, I must thank my office colleagues Ane Inger 
Søberg and Beate Stokke Solvik for valuable talks and support. To my colleagues at the 
pulmonary department; Astrid Kravdal, Øystein Stubhaug and Linea Brevik, thank you for 
teaching me and for cheering! 
My parents, Grete and Terje, have always been a great support and inspiration. They have 
thought me to work hard and to show interest in the patients, thank you! I would also like to 
thank my friends for valuable support and my in-laws for enthusiasm and valuable feed-back 
on methodological considerations about my work along the way.  
And lastly, to “my” Ola, thank you; for letting me complete this work while the kindergarten 
was locked down, for never complaining, for helping with my “commas” and for your smile 
in doing it all. Our two children, Haakon and Eirik are the biggest joy of my life and I thank 
you for reminding me of that every day! I hope my children will be as fortunate as me to be 
able to work with such amazing people and have fun while working.  
To the Bergen ILO group: to be continued… 
 
Astrid Sandnes 




Summary of thesis 
Background: Exercise-induced laryngeal obstruction (EILO) is an umbrella term describing 
inappropriate and transient closure of laryngeal structures during exercise, causing 
breathlessness and/or noisy respiration (stridor). EILO is a relatively prevalent entity, 
affecting adolescents or young adults in all activity levels. The condition has been reported to 
have a considerable functional impact, particularly as a limitation of physical activity in an 
effort to minimize the occurrence and severity of inspiratory symptoms. Objective 
visualization of the laryngeal obstruction and determining the level of obstruction within the 
larynx (supraglottic and/or glottic) during ongoing exercise is considered gold-standard for 
diagnosing EILO and seems of importance for subsequent treatment planning. Treatment 
options are based on weak evidence, with evaluation of different modalities mainly based on 
subjective outcomes. Information about the diagnosis and breathing advice (IBA) seems to be 
fundamental elements. Small studies and case reports suggests effect from speech therapy, 
biofeedback, inspiratory muscle training (IMT) and surgical supraglottoplasty. Robust 
treatment algorithms and follow-up streams are yet to be established.  
Aims: The overall aim of the thesis was to explore improvement of symptoms and laryngeal 
obstruction in EILO patients treated with IMT and supraglottoplasty in short- and long term. 
Study #I: To investigate laryngeal response pattern(s) during inspiratory muscle training 
(IMT) in healthy subjects using laryngoscopic evaluation and imaging. Study #II: To expand 
our knowledge and to explore possible effects from inspiratory muscle training in patients 
diagnosed with EILO. Study #III: To investigate the efficacy and safety of laser 
supraglottoplasty for patients with supraglottic EILO, using continuous laryngoscopy exercise 
(CLE) tests before and after surgery. Study #IV: To assess changes of self-reported symptoms 
and laryngeal outcomes shortly after IMT, and to compare self-reported symptoms with a 
control group 4-6 years later. 
Methods: Study design: An explorative approach with combined descriptive and quasi-
experimental observational design. Study #I: cross-sectional study, Study #II: prospective pre-
post study Study #III: retrospective pre-post study. Study #IV: follow-up study. Subjects and 
study procedures: Study #I: Twenty healthy volunteers examined with laryngoscopy during 
inspiratory muscle training (IMT). The laryngeal movements were retrospectively assessed 
from video files. Study# II and #III: EILO patients examined with continuous laryngoscopy 
exercise (CLE)-test before and after a treatment; six-week training program with IMT or 
supraglottoplasty. Outcome data were self-reported symptom scores and laryngeal obstruction 
(by CLE-scores from video recordings). Study #IV: Two groups were retrospectively 
identified from the EILO-register; one group receiving IBA only at diagnosis, and the other 
additionally receiving six weeks of IMT (IBA+IMT). Laryngeal outcome was assessed 
shortly after IMT, and the two groups’ self-reported symptoms were compared with a new 
questionnaire 4-6 years later.  
Results: Study #I: IMT facilitated laryngeal abduction in the investigated healthy subjects and 
application of medium intensity resistance seemed superior to higher resistance in opening of 
the laryngeal aperture. Study #II: IMT was safe and the perceived symptoms and laryngeal 
obstruction improved in subgroups of EILO after IMT, with improvement mainly observed at 
the glottic level. Study #III: Supraglottoplasty improved symptoms and reduced laryngeal 
obstruction in the investigated patients with predominantly supraglottic EILO and appeared 
safe in highly selected severe cases. Notably, supraglottoplasty might improve also glottic 
obstruction in patients with combined supraglottic and glottic obstruction. Study #IV: The 
response rate after 4-6 years was 40 % in the IBA-group and 55% in IBA+IMT-group. After 
2-4 weeks, 23/32 in the IBA+IMT-group reported symptom improvements, associated mainly 
with glottic changes, contrasting unchanged laryngeal scores in 9/32 without symptom 
improvements. After 4-6 years, self-reported exercise-related symptoms and activity had 
decreased to similar levels in both groups. Full symptom resolution was reported by 8/55. 
Conclusion: Self-reported symptoms and laryngeal obstruction as observed and rated in CLE-
tests can improve in EILO patients treated with IBA, IMT or supraglottoplasty. 
Heterogeneous responses to treatment were observed and substantiates that EILO is a 
heterogeneous condition, thus it is unlikely that one mode of treatment will work in all. 
Individual treatment and follow-up based on laryngeal findings seems essential.  
Future controlled studies with longer follow-up time are needed to establish effects from the 
treatment modalities applied in EILO patients. This work provides hypotheses that may serve 
as a basis in doing so.   
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Introduction 
Exercise induced laryngeal obstruction (EILO) refers to inappropriate transient closure of the 
larynx during exercise and is a common cause of exercise induced inspiratory symptoms. The 
work on removing a psychiatric connotation from this diagnosis has come a long way. 
Consensus is now established that EILO is a separate entity with symptoms only occurring 
with exercise as an inducer, and the diagnosis is made by endoscopic visualization of 
laryngeal structures during exercise. However, managing the patient group after a diagnosis 
has been established, is currently based on empirical data, and the research field of developing 
evidence-based treatment of EILO patients is at a very early phase. None of the applied 
treatment modalities have been investigated in controlled and randomized studies of larger 
patient groups, and evaluation after treatment has mainly been performed without verifiable 
outcome measures. (Literature search has been done regularly since October 2010 and for the 
last time on 1st September 2020).  
When we started to systematically explore and evaluate the laryngeal response patterns to 
different treatment modalities, little was known in this field, and we had to “find our way” 
based on the understanding at that time. We have now contributed to a new research field and 
made experiences to generate further hypotheses. This thesis serves as “one brick” to the 




1.1 EILO as a clinical entity 
Episodic occurrence of laryngeal obstruction has been described in detail throughout history 
(Appendix 1). The entity was mostly reported in psychiatric literature [4] before a description 
of five patients with “uncontrolled asthma” led to the name vocal cord dysfunction (VCD) [5]. 
Early reports focused on laryngeal obstruction at the glottic level, i.e., inappropriate adduction 
of the true vocal folds [5, 6]. Exercise recognized as a cause of transient inspiratory collapse 
of laryngeal structures has been described since the 1990s [7-11]. 
Despite the condition being known for decades, the research field is still at an early phase 
with primarily empirically based treatment modalities [6, 12]. Knowledge from different 
centers are difficult to match, pool or utilize by others due to; confusion in terminology with 
more than 85 different terms applied [4, 13-15], lack of standards for work-up and 
diagnostics, and lack of stratification and/or co-mingling symptoms induced by exercise and 
symptoms at rest caused by a variety of other triggers (psychogenic and irritant) [16, 17]. In 
2013, a consensus Task Force was commissioned to improve this situation with members 
appointed by the European Respiratory Society (ERS), the European Laryngological Society 
(ELS), and the American College of Chest Physicians (ACCP) [18]. The proposed 
ERS/ELS/ACCP taxonomy for exercise-induced laryngeal obstruction (EILO), rests on 
findings made by laryngoscopy performed from rest to peak exercise, a continuous 
laryngoscopy exercise (CLE) test [18-20]. The taxonomy requires visualization of the level of 
the obstruction within the larynx, i.e., glottic, supraglottic (or both), and what laryngeal 
structures incites the adduction.  
This thesis focuses on laryngeal obstruction induced by exercise, and ILO or EILO will be 
used throughout this thesis, also when referring to studies using different terminology. The 
term patient will be used throughout this thesis since the participants were referred to the 
clinic as patients.  
1.2 The site of obstruction: the larynx 
1.2.1 Laryngeal anatomy 
 
The larynx is a highly specialized and complex organ, which unfolds and folds cyclically for 
ventilation [21]. The rigid cartilage skeleton, the forceful ligaments and both abductor and 
adductor muscles makes larynx’s two main tasks possible; to secure an open airway during 
high volume ventilation, and to protect the lower airways from inhaling harmful objects [22]. 
These combined and often competing roles require fine-tuned control and rapid functional 
alterations [23]. The larynx extends vertically from the tip of the epiglottis to the inferior 
border of the cricoid cartilage. The laryngeal interior can be divided into supraglottic, glottic 
(vocal folds) and subglottic levels (Figure 1).  
 
 
The cartilage framework of the larynx protects from inspiratory collapse and consists of 
hyaline cartilages; the thyroid, the two arytenoids and the cricoid [24], suspended by muscles 
and ligaments (Figure 2). The epiglottis is composed of elastic cartilage, with the aryepiglottic 
folds extending backwards from the lateral margin and medially to the arytenoid cartilages, 
making a nearly circularly formed margin of the laryngeal inlet [21]. The aryepiglottic 
sphincter has a solely protective role of the lower airways.  
The muscles of the larynx can be divided in extrinsic and intrinsic muscles, all working as an 
integrated unit [25]. The extrinsic muscles move larynx as a whole, while the intrinsic 
muscles serve as abductors as well as stabilizers of the arytenoids and the attached 
aryepiglottic folds, and all act more or less directly on the glottis [23, 25]. The respiratory 
Figure 1: Overview of laryngeal landmarks and airflow. 
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functions of the larynx are initiated voluntarily but regulated involuntarily. The vocal folds 
are unique as they are under both autonomic and voluntary control [21-23, 26]. 
 
1.2.2 Laryngeal growth 
 
The supraglottic opening is relatively narrower in adolescents than in adults, with a 
significantly smaller laryngeal dimension in females than in males throughout puberty [27, 
28]. There is an accelerated growth of the vocal folds from 8 to 13 years in both sexes, but the 
male laryngeal cartilages and vocal folds quantitatively grows more [21, 29]. Also difference 
in the angle of the two laminae of the thyroid cartilage, respectively 75-90 degrees in adult 
males and 90 to 110 degrees in females, may affect airflow [21, 22]. The larynx reaches adult 
size around age 16-17 years [29]. Ossification commonly occurs in the laryngeal cartilages 
and starts as early as age 20 [21], which may add stability to the musculoskeletal system of 
the larynx [29]. The ossification may also reduce the flexibility of the larynx, particularly 
relevant in peak airflow conductance [22]. The growth and gender differences in the laryngeal 
opening may explain the reported age debut of EILO and the female preponderance seen in 
most epidemiological studies [30-32]. 
Figure 2: Cartilages of the larynx  
1.2.3 Larynx as a respiratory organ  
Airway resistance 
 
The role of larynx in respiration is primarily to maintain airway patency during inspiration 
and to keep airway resistance as low as possible [33], adjusted by movements of the vocal 
folds [34, 35]. Glottis forms the narrowest part of the respiratory tract, and generates 
turbulence of airflow because of the sharp reduction in airway cross-sectional area [21]. 
Larynx accounts for approximately 25% of the total pulmonary resistance during mouth 
breathing (at flow 1 L/s) [24, 33, 36]. During quiet breathing, the glottis opens more widely 
during inspiration than during expiration, enhancing or decreasing the resistance accordingly 
[24, 37-40]. Variations in the upper airway resistance is flow dependent as observed during 
panting and increased flow, which are associated with glottic widening [33, 37].  
Vocal fold movement 
 
Vocal fold movements are accomplished by rotation, tilting and anterior-posterior sliding of 
the arytenoid cartilages and are closely related to the diaphragm and other muscles of the 
ventilator pump [24]. Medial rotation brings the vocal folds together narrowing or closing the 
glottis. Opening of the laryngeal inlet is mainly accomplished by the posterior cricoarytenoid 
muscle (the PCA-muscle), attached posterolateral on the arytenoids, sliding and rotating the 
vocal processes outward (Figure 3).  
 
The PCA-muscle is the main abductor of the glottis [39], predominantly active during 
inspiration and acts in a phasic relationship with the diaphragm activity [21, 23, 41], hereafter 
Figure 3: Illustration of the posterior cricoarytenoid (PCA)-muscle,  
the main abductor of the larynx. 
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referred to as the PCA/diaphragm relationship. The PCA-muscle contracts several 
milliseconds prior to diaphragmatic contraction, before the onset of inspiratory flow, and its 
activity continues to a maximum reached approximately in mid-inspiration [37]. By 
physiological principles, laryngeal resistance must decrease exponentially as PCA activity 
increases [39]. The cricothyroid muscle tilts the thyroid forward, and when cricothyroid and 
the PCA-muscles contract simultaneously, a combined lengthening and abduction of the vocal 
folds occur, making the cross-sectional glottic area larger [23, 24]. 
1.2.4 Laryngeal function during exercise 
 
The normal laryngeal function during exercise is still not fully mapped out, but is essential in 
the further study of disease mechanisms in EILO [6, 12, 14]. At high airflow, the vocal folds 
and the arytenoids move to a relatively fixed abducted position, both in inspiration and also 
during expiration (contrasting the situation at rest) [8, 38, 42], thereby reducing the upper 
airway resistance [43]. The abduction continues into the expiratory phase and the larynx 
appears to play a significant role in determining the respiratory frequency, by determining the 
duration of expiration [38]. Simultaneously, the epiglottis flattens against the tongue base on 
inspiration, stretching the aryepiglottic folds allowing for increased airflow [24, 42].  
The normal findings have been reproduced in asymptomatic volunteers [11, 44, 45], with 
some variations. In a study by Beaty and colleagues [42], five of ten asymptomatic subjects 
significantly increased the laryngeal opening during exercise on a stationary bicycle, while in 
three the laryngeal aperture did not change. In the remaining two asymptomatic subjects a 
minor adduction of supraglottic structures during maximum exercise without any glottic 
adduction occurred. The same minor adduction was also found in 20 asymptomatic volunteers 
investigated by Røksund and colleagues [11], as well as in healthy controls and adolescents 
with exercise-induced dyspnoea without a diagnosis (i.e. neither EILO nor exercise induced 
bronchoconstriction, EIB), in a study by Norlander and colleagues [46]. Thus, some degree of 
supraglottic adduction may be a normal phenomenon during exercise. 
1.3 Exercise and breathing in general 
 
Pulmonary ventilation increases during exercise, induced by the increased metabolic demands 
of the body. At low intensity exercise, this is accomplished mainly by greater tidal volumes, 
while at higher intensities, the respiration rate also increases and the expiratory time decreases 
[38, 43]. The minute ventilation may rise 30 times over resting values, and in top athletes, 
maximal minute ventilation values of 280 liters per minute has been measured [43, 47]. As the 
airflow through the airways increases substantially, the turbulence in the upper airways will 
thus escalate. Athletes shift from predominantly nose to mouth breathing, which alters the 
pattern of airflow in the upper airways as well as the relative distribution of resistance within 
the airway tree. Active opening of the mouth tends to widen the laryngeal opening [40].  
The respiratory system is put under great stress during high intensity exercise and ideally, 
breathing is regulated in a way that maximizes the ability to perform. A top athlete demands 
more of the respiratory system than a recreational exerciser. Anatomy, physiological 
capacities, and the cardiopulmonary state are important factors contributing to the potential or 
the limitation of the respiratory system [48]. In addition, each exercise modality/sport has 
different challenges related to uninhibited ventilation, i.e., optimal conditions for the 
diaphragm and thorax expansion, dependent on body posture and breathing frequency. Factors 
such as increased intra-abdominal pressure when running, or the need to combine the motion 
of thorax expanding and contracting with the rowing stroke movement in rowing, can lead to 
additional challenges [49, 50]. During swimming, work of breathing is increased due to 
hydrostatic pressure against which the thorax expands, as well as short time for inspiration. 
Thus, subjects performing exercise modalities that require additional work from respiratory 
muscles, might be more susceptible to respiratory muscle fatigue [51]. The larynx also plays a 
role in some exercise modalities by facilitating elevation of thoracic and abdominal pressure 
by closure of the glottis [52].  
1.4 Aetiological aspects of EILO 
 
The pathogenesis of EILO is not fully understood, and causal theories are mostly based on 
speculations.                                  
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1.4.1 Aerodynamic aspects and breathing pattern 
 
The Bernoulli’s principle 
 
As described earlier, the larynx is a narrow part of the airway tree with large variation in 
resistance. As airflow through the larynx increases with increased exercise intensity, so does 
the negative inward pressure gradients over the laryngeal opening. The low cross-sectional 
area of the laryngeal aperture, leads to a pressure-drop that can lead to subsequent progression 
of obstruction at both glottic and supraglottic levels [8, 53], known as the Bernoulli’s 
principle [10, 54]. Particularly flaccid supraglottic or glottic structures can cause displacement 
of the air stream, resulting in greater turbulence [55]. Depending on the airflow velocity, 
turbulence, laryngeal architecture and the strength of the supporting structures, the tube will 
eventually yield to increased negative pressure within the tube [22, 23, 40, 56].  
The critical point of obstruction 
 
A low airflow resistance is obviously important to maintain high ventilation during exercise 
with a minimum amount of energy expenditure. Thus, coordination of the laryngeal muscles 
is highly significant when the ventilator requirements are high, and the last fraction of 
millimeters of glottic enlargement may be crucial [57]. Normally the airflow through the 
larynx is highest in the posterior part of the glottic aperture, when the dorsal parts of the vocal 
folds are lifted cranially [58]. The critical point of obstruction of the larynx required to 
produce symptoms in any given individual is difficult to assess, and probably depends on the 
timing of the breathing cycle, the airflow, the absolute size of the larynx or other individual 
differences [4].  
According to the law of Poiseuille, a reduction of the radius of the laryngeal opening will 
increase resistance to airflow by the fourth power of the radius. Therefore, a small degree of 
adduction in a subject with a wide larynx may have a different consequence for airflow 
resistance than the same extent of adduction in another subject with a narrower larynx. We 
have no knowledge on what are the normal or optimal relations between body size, ventilator 
requirements and the absolute size of the laryngeal aperture [6]. Focus on the remaining 
opening of the laryngeal inlet seems crucial for further investigations, and may explain why 
some patients reporting symptoms only have mild laryngeal adduction [11]. We do not have 
the technical tools to determine the absolute size of the laryngeal inlet, which is an important 
gap in our knowledge that needs to be filled. 
Epiglottis as contributing factor? 
 
A retroflexed epiglottis may disrupt airflow and create turbulence [25], and was found in 28 
of 113 EILO patients with simultaneous obstruction at glottic or supraglottic level, and in four 
of 23 asymptomatic subjects with otherwise normal laryngeal response to exercise [11]. 
Christensen and colleagues [30] reported on one subject with a peculiar flapping of the 
epiglottis during exercise, resulting in a staccato-like inspiratory sound, but without 
subjectively perceived symptoms. Retroflexed epiglottis has also been reported in the context 
of congenital laryngomalacia [59], and in mechanical insufflation-exsufflation in healthy 
subjects [60]. Hilland and colleagues [61] did not find epiglottis as a contributing factor when 
exploring EILO in patients with laryngomalacia in childhood. The contribution of epiglottis in 
relation to exercise induced inspiratory symptoms remains to be fully established.  
Influence of breathing patterns 
 
Fretheim-Kelly and colleagues [62] demonstrated in a study of seven healthy subjects, 
varying trans-laryngeal pressure patterns during exercise, reflecting that the breathing patterns 
differ between people with increasing minute ventilation. Some subjects increased tidal 
volume, whereas others increased breathing frequency. The time ratio of inspiration to 
expiration also varied, previously reported to be approximately 40:60 [24, 38, 39]. The timing 
of the breathing patterns may vary, but the volume of air must remain constant. If the 
resistance increases during inspiration, or the time of inspiration reduces, the flow must 
increase to get the same volume in. Inspiratory glottic and/or supraglottic dynamic obstruction 
likely affects work of breathing and respiratory physiology. Walsted and colleagues [63] 
found increased respiratory neural drive and thus increased ventilation (attributable to greater 
tidal volume) before observable laryngeal obstruction in six patients with EILO compared to 
six asymptomatic controls. However, whether patients with EILO adopt a breathing pattern 
with high tidal volume because they have increased airway resistance or if patients with 
increased respiratory neural drive is more likely to develop EILO, remains to be determined. 
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Inspiratory muscle fatigue 
 
Respiratory muscle fatigue is defined as the inability to sustain tension with repeated activity 
[64, 65], and may develop in healthy individuals during temporary increases in respiratory 
work, such as strenuous physical exercise [66]. The diaphragm is the primary muscle involved 
in active inspiration, but other inspiratory muscles may also be implicated by fatigue, such as 
the intrinsic laryngeal muscles. Fatigue of the posterior cricoarytenoid (PCA) muscle may 
lead to a smaller laryngeal aperture, as a tired muscle may be less able to resist the increasing 
negative intraluminal pressures on the laryngeal opening during high airflow rates, and 
possibly below a critical level for collapse [23, 67].  
1.4.2 Suggested causes, or co-morbidities leading to EILO 
 
Both asthma, gastroesophageal reflux syndrome (GERD) [26, 68] and nasal disease [69] have 
been suggested as causes or contributing factors leading to EILO, with variable scientific 
evidence. GERD leading to a sensitized larynx has been contradicted by others [70, 71], and 
treating EILO patients with proton pump inhibitor has not proven effective in reducing 
symptoms [72]. Activation of pressure- and flow receptors in the supraglottic mucosa may 
lead to laryngeal hyper-reactivity [23, 73, 74] but evidence lack to support this theory [14]. As 
EILO and exercise induced bronchoconstriction (EIB) may co-exists [30, 75, 76], it is not 
unlikely that patients with EILO also reacts to rapid inspiration of cold air by the same 
mechanisms [43, 77, 78]. Anecdotal reports on worsening of symptoms in EILO during cold 
and humid air [76, 79] and reports of higher frequencies among athletes participating in 
outdoor than indoor activities, suggest influence of environmental factors [80]. However, 
EILO is seen across most sports activities.  
The findings of supraglottic collapse in EILO is similar to observations in newborns with 
congenital laryngomalacia (CLM) [8, 10, 81, 82], thus the (previously) often used labels 
exercise-induced laryngomalacia and adult-onset laryngomalacia. However, one of the 
anatomical hallmarks of laryngomalacia, an omega-shaped epiglottis, occurs also in healthy 
persons [8]. There are no studies to date that indicate that EILO in general can be explained 
simply by CLM. Plausible modes of inheritance have been suggested [61, 83], but no definite 
proof of a hereditary component exist. 
Psychological factors 
 
Many publications have emphasized a psychological component of EILO [26, 84, 85], 
primarily based on a small study from the 1990s presenting a link between sexual abuse in 
early childhood and ILO [86]. However, this has not been substantiated scientifically [16, 79]. 
To date, overrepresentation of psychiatric disease or personality disorders have not been 
documented in patients with isolated EILO [16]. High achievers are pointed out as typical 
EILO patients in numerous publications [16, 26, 87]. However, this may also reflect 
temperaments in competitive young athletes in general, as well as athletes being more 
perceptive to minor airflow disturbances during exercise than more sedentary persons [76]. 
1.4.3 EILO subgroups or “phenotypes” 
 
The ERS/ELS/ACCP Task Force taxonomy established a consensus that laryngeal obstruction 
can occur at the supraglottic level or the glottic level or a combination of the two, and 
proposed there were at least two “EILO subgroups”, i.e. glottic and supraglottic EILO [18]. If 
this represents simultaneous presentation of two different pathophysiological or adaptive 
processes, or if there is a causal link between the two is not known [88]. This distinction could 
be of importance as the cause and therapy strategies of these two conditions may differ [1]. 
Given the complexity of the human larynx and its compound and sometimes conflicting tasks, 
it seems unlikely that a single factor can explain the entire range of manifestations of EILO 
[79]. Corresponding heterogeneities regarding exercise induced malfunction should therefore 
be expected [6]. Further studies are needed to establish the etiology/etiologies for EILO. Until 
then, development of treatment modalities is still based on targeting symptoms or 
pathophysiological aspects of the condition.  
1.5 Epidemiology 
Exercise-induced respiratory complaints are common, reported in 12-14% among college 
athletes [89] and in 14% among Swedish adolescents [90]. EILO is an increasingly well-
recognized cause of exertional dyspnea in the young [91], but key epidemiological data such 
as prevalence, incidence, age and gender distribution as well as the ratio of exercisers versus 
top athletes are not fully known in the general population. The material published is 
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influenced by the varying diagnostic criteria employed, and published cohorts may be 
influenced by referral bias [79].  
Occurrence rates of 5% to 7% of the adolescent population have been proposed [30, 32, 80]. 
A cross-sectional study of adolescents aged 14-24 in Copenhagen tested 98 of the 556 invited 
subjects with a CLE-test [30]. The tested subjects all reported exercise-related symptoms, and 
the diagnosis of EILO was set in 42 (43%) of the tested subjects, calculating a minimum 
prevalence of 7.5%. Other reports found EILO in 12% of active duty military patients with 
exertional dyspnea [92] and 11% in a suburban pulmonary practice [93].  
Patients usually presents with symptoms of EILO in adolescents/young adulthood [79], but it 
is not known if the condition itself develops during this time-period, or if it is due to increased 
ventilator requirements occurring at this age due to participation in competitive sports and 
physical education at school. Most studies report a female predominance [30, 31]; however, 
not necessarily for prepubertal populations [32].  
The description of affected patients in the literature range from elite athletes [26, 87] to 
moderately active children and adolescents affected in normal activity and play [94]. EILO is 
reported to be frequent in athletes [95], with up to 35% (n=31) of athletes with exertional 
dyspnea found to have EILO in a retrospective study [31]. However, only athletes with 
symptoms were investigated and not a random sample of athletes. Rundell and colleagues 
[80] observed “inspiratory stridor” during an exercise test in 5% of 370 athletes; however, 
without endoscopic evaluation, leaving the question if some might have passed undetected. A 
new cross-sectional study from Ersson and colleagues estimated the prevalence of EILO to be 
8.1% in adolescent athletes [96].  
Based on the current reports, EILO is likely to be relatively frequent in adolescents, and thus 
there might be a large group of patients with unmet needs who may request treatment for their 
breathing problem after diagnosis.  
1.6 Exercise induced respiratory symptoms and differential diagnosis 
 
Perceived breathlessness during exertion is reported as the most common symptom limiting 
sporting performance in children and adolescents [97], with the most common cause being 
poor physical fitness [98]. The sensation of breathlessness/dyspnea is a complex and highly 
subjective experience [99-101], that likely develops during a continuum as the demand for 
ventilation exceeds the capacity to provide it [101]. Some adolescents may interpret dyspnea 
associated with normal physiologic limitation consistent with their abnormal physical fitness 
level [14, 102]. In a cross-sectional study of Swedish adolescents by Johansson and 
colleagues, 49% (n=51) of participants reported exercise-induced dyspnea, but had neither 
exercise induced bronchoconstriction (EIB) nor EILO when tested according to guidelines for 
these two conditions [32]. There is a need of more normal comparatives in further 
investigations to establish when exercise induced inspiratory symptoms (EIIS) become 
abnormal (Figure 4).  
 
A variety of respiratory problems can limit performance. Structural airway abnormalities, 
cardiac diseases, primary hyperventilation, poor breathing techniques or psychological causes 
are possible explanations [103].  
Exercise induced asthma (EIA) or exercise induced bronchoconstriction (EIB) is a well 
described disease, often relevant to young people. EIB is reported to be present in 8-10% of 
an unselected Norwegian childhood population [104], and in 20–50% of athletes [80, 89, 96, 
105, 106]. The pathophysiology of EIB is beyond the scope of this thesis, and therefore not 
discussed. Evaluating EILO and EIB is challenging and several clinical features may overlap, 
despite their highly different pathophysiological background.  
The main difference of the two conditions is that symptoms in relation to EILO develops 




inspiration phase of respiration, and usually disappears 2-3 min after exercise ceases [4]. 
Patients with EIB on the other hand, can manage well during ongoing exercise, but experience 
expiratory breathing difficulties and wheeze usually 3-15 min after exercise termination [78]. 
In patients with EILO, respiratory symptoms are often erroneously attributed to poorly 
controlled asthma, with overmedication and unnecessary medications as a consequence [31, 
32, 107, 108]. However, the two conditions may co-exist [30, 75, 76], with reports of 5-10% 
[30-32] to up to 30-40% comorbidity [4, 76, 109, 110]. The frequent co-morbidity of the two 
conditions may explain persistence of exercise-related symptoms due to EILO in spite of 
optimal asthma therapy in some patients [30]. Also, excessive laryngeal closure during 
exercise, both supraglottic and glottic and both inspiratory and expiratory, has been reported 
to be apparent in patients with asthma [111, 112]. Thus, laryngeal malfunction might be an 
integrated part of asthma. Bearing in mind the two conditions when evaluating exercise-
induced respiratory complaints seems of importance.  
1.7 Symptoms of EILO 
Dyspnea during exercise is the most common cited symptom in EILO patients in the clinical 
literature [17], attributed to the inspiratory phase of the respiratory cycle [6, 14]. However, 
complaints of dyspnea on expiration have also been reported [109, 113] and patients may be 
unable to attribute respiratory symptoms to a specific respiratory phase. Other symptoms 
presented in a sequence of events are throat tightness/chocking sensation, chest tightness, 
noisy breathing/stridor, hoarseness/voice change and cough [4, 11]. Stridor, a high-pitched 
musical sound, is produced when turbulent airflow is located in the upper respiratory tracts, 
and during exercise, often attributed to adduction of the vocal folds, but not necessarily linked 
to one anatomical structure or causal factor [11]. Relatively similar symptoms of EILO may 
be interpreted differently by the individual depending on the circumstances and the history of 
similar sensations [101] and factors relating to personal ambitions and lifestyle [91, 97]. A 
better understanding of perceived symptoms corresponding to the degree of the laryngeal 
obstruction is an unmet need in the research field of EILO. 
1.8 Diagnostics of EILO 
A correct diagnosis of exercise induced respiratory symptoms may be challenging for the 
clinician [114]. To diagnose EILO, the patient must report exercise induced problems, and the 
physician must be aware of the condition and know how to confirm the diagnosis.   
1.8.1 Symptoms and clinical evaluation 
 
Several questionnaires are now available suited for monitoring and measuring symptoms in 
EILO [115-118], with good test-retest reliability in quantifying patients’ symptoms [118]. 
However, none have yet been validated as a diagnostic tool [79, 119]. Structured history and 
detailed symptom description may provide important diagnostic clues, but there is no proven 
value of structured symptom assessment as per questionnaires in screening for EILO [88]. 
Self-reported symptoms are often poor predictors of EILO [31, 32, 120]. No specific 
symptom could be used to differentiate between EILO and EIB in neither an interview-based 
questionnaire of 150 adolescents [30] nor in a clinical interview of 88 athletes with exertional 
dyspnea [31].  
Similar symptom presentation may arise from the different EILO subgroups, and symptom-
based questionnaires cannot easily replace endoscopic evaluation.  
1.8.2 Pulmonary diagnostics/surrogate measures 
 
Measurement of airflow to detect upper airway obstruction are described as useful tools in 
diagnosing EILO. Spirometry with flattened or truncated inspiratory loop [118], eucapnic 
voluntary hyperventilation [121, 122], bronchial provocation testing with inhaled histamine or 
methacholine [123, 124], impulse oscillometry and airway perturbation device [125-127] have 
all been suggested on that matter. To date, both specificity and sensitivity of these measures 
are either unknown or low [109, 128-130], as well as the reproducibility of inspiratory volume 
loops. Nevertheless, lung function test at rest may give important information in 
discrimination from relevant differential diagnoses.  
1.8.3 Continuous laryngoscopy exercise-test 
 
The diagnosis of EILO is based on direct visualization of supraglottic and/or glottic narrowing 
in correlation with characteristic symptoms [79]. Studies from the 1990s reported on flexible 
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laryngoscopy applied in patients before and after exercise [26, 87]. As high airflow quickly 
decreases after exercise, the obstruction may have resolved before introducing the scope. 
Thus, the method of introducing the laryngoscope after exercise to diagnose EILO entails a 
high risk of false negative results. Flexible laryngoscopy during exercise on an ergometer 
bicycle was first described in 1994 [9] and during various body movements in 2000 [52]. The 
continuous laryngoscopy exercise test (CLE-test) enables visualization of the inciting 
structures (supraglottic or glottic) and the development of closure, and is now considered gold 
standard for diagnosing EILO [3]. (Link to web-source explaining the test: 
https://www.youtube.com/watch?v=N42UevZWKgA). 
The CLE-test has been applied in large studies of symptomatic EILO patients and symptom-
negative controls [11, 30, 32, 44]. The methodology has been adapted to different exercise 
modalities such as ergometer bicycling [44], rowing [50] and swimming [120]. Thresholds of 
exhaustion differs between testing disciplines [131], which may lead to differences regarding 
inducing symptoms. Therefore, it is beneficial if the laboratory allows patients to perform 
CLE while performing their specific activity that usually induces their symptoms [50]. The 
method of CLE requires a comprehensive laboratory set-up and skilled personnel, as well as 
experience in evaluating the results. Combining ergospirometry with CLE provides valid 
measurements of the maximal oxygen uptake [94] and may provide important diagnostic 
clues but is not considered necessary for the diagnosis of EILO.  
1.8.4 Evaluation of laryngeal obstruction 
 
Proposed methods for evaluating the severity of obstruction from the laryngeal images 
obtained from the CLE-test are; image quantification to estimate the laryngeal anterior-
posterior diameter or the anterior glottic angle [43, 132], computerized calculations with the 
“EILOMEA method” [133] and the “CLE-scoring system” (or “Maat score”) [1, 134]. The 
EILOMEA method is based on a rater-selected laryngeal image of the maximum inspiratory 
obstruction at moderate and at maximum exercise intensity, and requires specially developed 
soft-ware [133]. More widely used is the CLE-score, based on subjective evaluation by the 
rater according to a pre-set scheme, evaluating the degree of obstruction from 0 (complete 
patency) to 3 (almost complete obstruction) at glottic and supraglottic level and at moderate 
and at maximum intensity (see Figure 7 page 42) [1]. Consistency between the EILOMEA 
and the CLE-scores have been evaluated and found to be acceptable [134], except for mild 
glottic obstruction (change from 0 to 1) at maximum exercise possibly being underestimated 
by the CLE-score compared to the EILOMEA method [46, 134].  
The diagnostic cut-off values have been debated for the two methods, emphasizing a need for 
more material on “normal” laryngeal movements during exercise [135]. Typically a CLE-
score ≥ 2 glottic or supraglottic is “diagnostic” for abnormal laryngeal closure [1, 46, 133], 
and have been applied in several clinical studies [46, 136, 137].  
The degree of laryngeal obstruction is reported to correlate well with observed symptom 
presentation [1], with some outliers; i.e., young athletes who continue to run despite severe 
symptoms of distress and relatively extensive laryngeal obstruction, while others stop early 
with seemingly minor symptoms and an open larynx. Today we cannot predict in any way 
exactly at what degree of narrowing the breathing of any given person is subjectively 
hampered (Figure 4). Thus empirically defined CLE-score cut-off values are not necessarily 
adequate in a clinical setting, emphasizing the importance of evaluating also the patients’ 
subjective experience in relation to the objective clinical findings [46].  
1.9 Treatment modalities in EILO 
The optimal approach for treating EILO remains to be determined as the published evidence-
base on EILO treatment is heavily influenced by anecdotal reports and retrospective reviews, 
with small sample sizes and unclear outcome measures [17, 138]. Most reports are solely 
based on subjective reporting of symptoms before and after an intervention. Only a few have 
used visualization of the laryngeal response as an outcome measure. There are currently no 
published randomized controlled treatment trials, and treatment of EILO has been said to 
represent an “evidence free zone” [118]. See treatment overview in Appendix 1.  
The common goal for treatment measures is to relieve the perception of exercise induced 
respiratory symptoms. Some of the modalities that have been applied in an attempt to relieve 
symptoms during exercise are; psychotherapy [139], speech therapy [140-143], inhaled 
ipratropium bromide [144], different forms of biofeedback techniques [145, 146], inspiratory 
muscle training [147-151] and laser supraglottoplasty [152-155]. 
The heterogeneity of findings when investigating EILO patients [11] indicate that better 
subgrouping of EILO may facilitate individually tailored treatment, and increase success rates 
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for different treatment modalities [79]. Benefits from a multidisciplinary team (MDT)-
approach for treating EILO has also been highlighted [136, 156]. Further development of 
treatment options and proper evaluation of the response patterns after interventions are 
needed. 
1.9.1 Information and biofeedback  
 
The first aim of treating EILO is educating 
the patient about the diagnosis, the 
prevalence, its trigger factors and 
reassurance to the patient/and caregivers that 
the condition is not life-threatening [6, 141, 
157], despite the fact that symptom 
presentation can sometimes seem so. A 
multidisciplinary approach on a single visit 
with visual biofeedback of laryngeal 
responses, patient education, breathing 
exercises and relaxation techniques from 
speech therapy is reported to reduce 
symptoms and maintain or increase the 
activity level of patients, regardless of EILO subgroup [146]. Simply observing their own 
malfunctioning larynx has been reported to help in most patients with mild or moderate 
disease [141, 145] (Figure 5). The structured information and breathing advice given to all 
patients at our institution has been named IBA; information and breathing advice. However, 
these techniques take time to learn [158] and they require practice to apply the techniques 
during high intensity exercise. Olin and colleges [145] reported on the first systematic use of 
therapeutic laryngoscopy during exercise (TLE) in an uncontrolled study. Three quarters of 
the participants (total n= 64) reported subjective effectiveness of the technique [145, 159]. 
The Olin Exercise induced laryngeal obstruction Biphasic inspiration (EILOBI)-breathing 
techniques is based on a principle that sudden changes in airflow during inhalation seem to 
positively affect inspiratory laryngeal configuration [145, 159, 160]. The “Hull-Hoover 
technique” is another described technique that encourages athletes to work around creating 
audible sounds replicating the word “hoover” to modulate airflow both on inspiration and 
Figure 5: Visualization of laryngeal responses 
on the monitor, i.e. biofeedback 
expiration [158]. A recent study evaluating specialized physiotherapy targeting breathing 
pattern, in combination with elements of cognitive behavioural therapy, reported improved 
subjective respiratory symptoms and reduced laryngeal obstruction during CLE-test in four 
athletes with EILO [161]. Overall, the findings of the different techniques are preliminary and 
suggest a reasonable rationale for proceeding to better planned studies as they also can be 
applied during high-intensity training. 
Efficient breathing patterns during exercise can to a certain extent be trained [141], but may 
not be sufficient for a top athlete that must increase both tidal volume and breathing frequency 
to improve ventilation at maximum exercise intensity.  
1.9.2 Speech therapy/Laryngeal control therapy (LCT)  
 
Speech therapy is reported as the mainstay of conservative treatment in EILO patients [140, 
141, 146], with 75-80% of patients reporting subjective improvement in uncontrolled studies 
[141]. Various breathing techniques guided by a speech language therapist (with or without 
laryngoscopy) is applied to gain respiratory control and self-awareness of sensations of 
laryngeal tension [141, 157, 162]. The techniques may require adjustment for application 
during exercise, and athletes are encouraged to practice techniques daily [141, 157].  
A systematic review on speech-therapy in ILO, not differentiating the inducer of symptoms, 
found that the evidence for its use is in its infancy with the majority of studies being in the 
exploratory stage of research [143]. Speech therapy remains to be validated by well-controlled 
treatment trials in patients with EILO using standardized outcome measures [146]. When need 
for multiple sessions, this “one-to-one” treatment by a speech therapist may be perceived as 
resource-demanding in a country with long travel distances, such as Norway. 
1.9.3 Inspiratory muscle training 
 
Inspiratory muscle training in general 
 
Inspiratory muscle training (IMT) is a form of respiratory muscle training (RMT) and is based 
on a course of breathing exercises with resistance during inspiration, loading the inspiratory 
muscles during the training session. IMT aim to strengthen the inspiratory muscles and 
increase the endurance [163, 164], and is usually split into two training modalities (Table 1): 
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Table 1: Training modalities of inspiratory muscle training (IMT) 
 Inspiratory muscle 
STRENGTH training (IMST) 
Inspiratory muscle 
ENDURANCE training (IMET) 
Intensity and force HIGH LOW 
Velocity of muscle 
contractions 
LOW HIGH 
Duration of stimulus SHORT LONG 
 
The respiratory muscles are morphologically and functionally similar to skeletal muscles and 
can be trained both for strength and endurance [163]. IMT have been used in both healthy and 
in patients with respiratory system impairment to strengthen the diaphragm and other 
respiratory muscles to enhance breathing efficacy [49]. Conflicting results on the 
effectiveness from IMT on improvement of sports performance in general in healthy subjects 
have been reported [165, 166]. The putative mechanisms to explain improved exercise 
performance from IMT include; decreased perceived breathlessness, strengthening the 
respiratory muscles and hence minimizing respiratory fatigue, and reducing the metaboreflex 
phenomenon [65, 165]. In response to inspiratory muscle fatigue and dyspnea, the 
metaboreflex may redistribute blood flow to the respiratory muscles while decreasing blood 
flow to the activated peripheral musculature. However, the literature appears inconclusive on 
the field of IMT and exercise performance enhancement [167], and appears beyond the scope 
of this thesis.  
In general, muscular strength increases as a result of adaptive changes and altered neural drive 
during the first weeks of training [168]. Chronic training increases the passive stiffness of 
locomotor muscles and thereby increase the intrinsic stiffness, which may reduce a tendency 
for upper airway collapse [169, 170].  
There are several IMT-devices available on the commercial market using different principles 
of resistance (Table 2), which can be controlled by factors such as time, intensity and/or 
frequency of training. There are no evidence based guidelines for which modality or how to 
build training programs for different clinical situations [49].  
 
Table 2: Types of inspiratory resistance applied in inspiratory muscle training (IMT) 





















Inspiratory muscle training and EILO 
 
IMT is suggested as treatment for EILO because of the PCA/diaphragm-relationship [37]; 
facilitating enhanced diaphragmatic strength will also lead to enhanced laryngeal abduction. 
This was first described clinically in a case report from Archer and colleagues [171], using an 
improvised inspiratory muscle trainer made of anaesthetic equipment that improved the 
patient’s symptoms when used during symptoms of ILO at rest.  
Application of a training stimulus as IMT in EILO will possibly lead to:  
1) Facilitation of a more effective and better controlled laryngeal abduction due to a 
better controlled or a stronger PCA/diaphragm-relationship [45], leading to delay (or 
prohibition) of airway obstruction. 
2) Less tendency for upper airway collapse due to increased active (neural) tone and 
passive (intrinsic) stiffness of the dilators, or both [169].  
3) Increased inspiratory muscle strength including intrinsic laryngeal muscles, leading 
to generation of a smaller fraction of maximal force in the respiratory muscles with 
each breath and thereby decreasing the sense of effort [148]. 
At the laryngeal level, the degree of load-dependent abductor activity appears to vary directly 
with ventilator resistance [23], and resistive loading during inspiration have been found to 
increase the inspiratory activity of laryngeal abductors in anesthetized animals [24]. To what 
extent application of IMT facilitates the desired response of a larger laryngeal opening had so 




Table 3: Publications of IMT in EILO 
IMT: Inspiratory muscle training; Pimax: Maximal inspiratory mouth pressure; CLE-test: continuous laryngoscopy exercise-
test; IBA: information and breathing advice with biofeedback.  
* published after paper #II of this thesis 
Studies proving that IMT affects EILO are scarce. To the best of our knowledge, only ten 
cases of IMT used to treat EILO patients have been published, evaluating both threshold 
training and resistive load training (Table 3). Eight cases reported subjective effect, one 
unchanged and one reported worsening [147-150, 172]. The studies are hard to compare due 
to variabilities between the participants, the device and protocol applied and the use of 
different outcome measures. 
1.9.4 Pharmacological therapies 
 
Several pharmacological agents have been used to decrease the impact from triggers of ILO 
[173], but as with reports of other managements many of the studies do not differentiate 
among patients with symptoms at rest or induced by exercise. Inhaled anticholinergics before 
exercising are reported to reduce symptoms in EILO, explained by reducing the sensory 
mediated laryngeal closure [144, 174]. Also, heliox, a combination gas of helium and oxygen 
[175, 176], botulinum toxin injection [156] and proton pump inhibitor (PPI) [72, 177] have 
been suggested, all of which currently lack support of evidence.  
Authors, year Case(s) IMT intervention Outcome 
Ruddy  
et al, 2004 
A 15-year-old male rower Pressure threshold loading for 6 weeks 
and one session behavioural 
therapy/week  
 
Pimax, subjective scoring of 
dyspnea and exercise testing 
Mathers-
Schmidt  
et al, 2005 
A 18-year-old female 
soccer player 
Pressure threshold loading 5 weeks on-
off (total 16 weeks) and one session 
behavioural therapy 
Pimax, subjective scoring of 
dyspnea, exercise testing and 
laryngoscopy after exercise 
 
Dickinson  
et al, 2007  
A 25-year-old athlete Pressure threshold loading for 11 weeks Pimax, subjective scoring of 
dyspnea and exercise testing 
 
Clemm  




et al, 2020 
A 18-year-old male athlete 
and a 20-year-old female 
athlete 
 
Five athletes  
aged 10-16,  
(one male, four females)  
Flow-resistive loading for 6 weeks and 
one session with IBA 
 
 
Pressure threshold loading for 5 weeks 




Subjective scoring, maximum 
phonation time and duration of 
running. 
Total 10   
1.9.5 Supraglottoplasty 
 
The method of endoscopic supraglottoplasty was first described in patients with supraglottic 
obstruction and “adult laryngomalacia” in 1995 by Smith and colleagues [81]. The aim of the 
procedure is to reduce the possibility of supraglottic collapse, and to increase the structural 
integrity of the supraglottic structures. The procedure was based on the surgical technique 
used to treat congenital laryngomalacia. Subsequently, different surgical techniques such as 
cold steel and laser for supraglottoplasty have been applied.  
Initially published case reports demonstrating effect from supraglottoplasty in supraglottic 
EILO [8, 10, 41, 54, 59, 178-180] have in recent years been followed by larger series of 
patients [137, 152-155] (Table 4).  
Table 4 Reports of supraglottoplasty in exercise-induced laryngeal obstruction 
Studies published in English (or abstract in English) were identified from search in PubMed 
CLE-test: Continuous laryngoscopy exercise-test 
* published after paper #III of this thesis 
a) Sandnes et al, 2019 (Study #III of present thesis),n=45 evaluated with symptoms and CLE-test before and after in all 
Authors, Year Cases Examination before surgery Examination after surgery 
Smith et al, 1995     1 Exercise and laryngoscopy CLE-test 
Bent et al, 1996   2 Exercise and laryngoscopy CLE-test in one 
Björnsdottir et al, 2000 2 CLE-test CLE-test 
Chemery et al, 2002  1 Laryngoscopy after exercise Laryngoscopy after exercise 
Mandel et al, 2003 1 Laryngoscopy and spirometry Laryngoscopy and spirometry 
Richter et al, 2008 3 CLE-test CLE-test 
McNally et al, 2010 
 
Maat et al, 2011 
    1 
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Laryngoscopy post exercise 
 
CLE-test 
Symptoms and laryngoscopy  
after exercise 
CLE-test in 19  
Dion et al, 2012 3 Exercise flexible laryngoscopy Exercise flexible laryngoscopy 
Orbelo et al, 2014 1 Exercise flexible laryngoscopy Exercise flexible laryngoscopy 
Norlander et al, 2015 14 CLE-test Symptoms  
Mehlum et al, 2016 17 CLE-test Symptoms in 15 and CLE-test in 11 
*Famokunwa et al, 2020 19 CLE-test Symptoms and CLE-test in 14 
Total  88 a) 
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All studies indicate that surgery has a beneficial impact on EILO-related symptoms, and the 
literature suggest that the procedure is safe, based on descriptions of surgical treatment of 69 
cases worldwide prior to 2018 [181, 182]. The published data may be confounded by 
selection bias due to lack of a randomized approach to patient selection with only highly 
motivated patients included, and only a few studies used laryngoscopy during exercise to rate 
the success postoperatively [152, 154].  
To the best of our knowledge, no serious complications after supraglottoplasty on EILO 
patients have been reported to date. No studies have evaluated the optimal surgical technique, 
and in fact, many of the published studies do not specify the technique applied. Only the study 
by Maat and colleagues evaluates long-term effect of surgery using laryngoscopy [152].  
1.10 Follow-up of EILO after treatment 
The natural course of EILO is unknown. To the best of our knowledge, only three studies 
have investigated long-term symptoms in patients with EILO [144, 152, 155], and there are 
currently no studies with information covering more than five years of follow-up after 
diagnosis. Experience from congenital laryngomalacia suggest that laryngeal abnormalities 
originating at a young age may resolve naturally with growth and maturation [183, 184]. This 
scenario has led some researchers to postulate that growth of the larynx would naturally 
reduce/resolve EILO in adolescents. Thus, they hypothesize that young patients with EILO 
“will grow out of the problem” through maturation and growth of the larynx [29].   
In a study of 17 EILO patients [144], where six initially were treated with inhaled 
ipratriopium bromid before exercise, 16 reported spontaneous resolution of symptoms at a 
median time of 5 months after diagnosis (variability from 1 week to 5 years). One still used 
inhalation treatment before exercise at follow-up. However, 6 of the patients had quit their 
competitive sports activity which was the original trigger of their symptoms.  
A retrospective study of 19 surgically and 14 conservatively treated EILO patients re-
examined 2-5 years after (and age > 20) [152] found reduced self-reported symptoms and 
improvement of laryngeal obstruction during exercise (evaluated by CLE-test) with 
normalization in 16/19 treated with supraglottoplasty compared to 3/14 of the conservatively 
treated. Similar findings were presented in a symptom-based follow up study 1-3 years after a 
diagnostic CLE-test. By comparing, surgically treated versus conservatively treated, they 
found subjective improvements of symptoms only in the surgically treated group [155]. In 
both studies, the activity level was also reduced, so we do not really know if symptoms had 
declined per se or if symptoms were less bothersome due to less exposure to the trigger.  
The few published follow-up studies of EILO collectively suggest that laryngeal obstruction 
does not improve with age, whereas symptoms might improve, possibly due to reduced 
physical activity and/or changes of exercise habits.  
1.10.1 The EILO-register 
 
In our hospital around 200 CLE-tests are conducted annually. Aiming to collect information 
about the EILO patient population, their laryngeal response patterns, evaluation after 
treatment interventions and to observe how the condition generally progresses. The EILO-
register was created in January 2013 (REK 2016/1898). Inclusion is consent-based with a 
good overall cover ratio, only one patient has declined to be registered so far. The register 
data are obtained from the patient and the clinician and stored unidentified. Variables of 
interest are age, gender, self-reported debut of respiratory symptoms, previous diagnoses, use 
of asthma medication, type and level of sports, hours of physical activity per week, exercise 
symptoms and their influence on daily life. Data are obtained from an established 
questionnaire, the CLE recordings with scores, and the ergospirometry data. The treatment 
choice and further referrals for comorbidities are noted by the clinician.  
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2. State of the art 
Exercise as an inducer of laryngeal obstruction was reported over two decades ago, but our 
understanding of the disease entity is still rudimentary. There are still unanswered questions 
about the etiology, prevalence, effects of treatment, prognosis and natural course of EILO. 
Still, some improvements have been made the last years. One important milestone was the 
establishment of endoscopy performed during ongoing exercise as gold standard for making 
an EILO diagnosis. A setup for continuous laryngoscopy during exercise [3] is now widely 
used. This was important for the taxonomy established by the “ERS/ELS/ACCP Task Force” 
group in 2013, settling EILO as the overall term for airflow obstruction at the laryngeal level 
during high intensity physical exertion [13]. The term has been fully adopted in Europe, 
whereas the condition is still known predominantly as VCD in Australia, and in the United 
States as paradoxical vocal fold motion (PVFM) [136].  
The “semi-objective” classification of EILO severity by CLE-score most employed, still 
represents a rather crude approach. Subjective perception of exercise symptoms does not 
always match CLE-score findings. Outcome tools to quantify the subjective impact of EILO 
or evaluation after treatment are currently an important unmet need in this research field.  
Different treatment modalities offered varies between centers but are in general based on 
empirical data and lack high-quality evidence. Development of robust treatment modalities 
seems important from a health care perspective, as the debut age of EILO is also a vulnerable 
age for decline in sporting activities. Preliminary findings in treatment studies warrant further 
investigations. At our institution during this study, first-line therapy for EILO (received by all 
patients) was information about the condition and physician-guided structured breathing 
advice while patients were observing their laryngeal responses on the monitor (biofeedback), 
hereafter referred to as IBA. Second-line treatment options were physician-guided IMT or 
speech therapy, offered to patients based on the degree of laryngeal obstruction, perceived 
symptom severity, patient motivation, and the availability of the apparatus/speech language 
pathologist. Supraglottoplasty was reserved for highly selected supraglottic cases. Proper 
long-term follow-up of conservatively and surgically treated EILO is needed. The EILO 
register at Haukeland University Hospital is (and will be) an important tool in the process of 
collecting more data on EILO and to perform long-term follow-up.  
3. Aims of the thesis 
The overall aim of this study was to explore short- and long-term influence on laryngeal 
obstruction and subjective symptoms in EILO patients treated with inspiratory muscle training 
or laser supraglottoplasty.  
3.1 Specific aims of the studies  
Study #I: To investigate laryngeal response pattern(s) during inspiratory muscle training 
(IMT) in healthy subjects using laryngoscopic evaluation and imaging. 
Research question #1: Can laryngoscopy confirm the relationship between the 
diaphragm and the posterior cricoarytenoid (PCA)-muscle by visualizing laryngeal 
abduction in healthy subjects?  
Research question #2: Does inspiratory muscle strength training (IMST) influence 
the size of the inspiratory laryngeal aperture in healthy subjects? 
Research question #3: Does inspiratory muscle endurance training (IMET) influence 
the size of the inspiratory laryngeal aperture in healthy subjects? 
 
Study #II: To expand our knowledge and to explore possible effects from inspiratory muscle 
training in patients diagnosed with EILO.  
Research question #4: Does six-weeks of IMT influence self-reported exercise 
induced respiratory symptoms in patients with EILO? 
Research question #5: Does six-weeks of IMT influence the laryngeal obstruction 
(evaluated by CLE-score) during exercise in patients with EILO? 
 
Study #III: To investigate the efficacy and safety of laser supraglottoplasty for patients with 
supraglottic EILO, with CLE-tests performed before and after surgery.  




Research question #7: Does supraglottoplasty influence self-reported exercise 
induced respiratory symptoms in patients with supraglottic EILO? 
Research question #8: Does supraglottoplasty influence the laryngeal closure 
(evaluated by CLE-score) in patients with supraglottic EILO? 
 
Study #IV: To assess changes of self-reported symptoms and laryngeal outcomes in EILO 
shortly after treatment with standardized information and breathing advice (IBA) plus IMT. 
After 4-6 years, comparing self-reported symptoms in the same individuals with a control 
group with EILO who had only received IBA.  
Research question #9: Does self-reported exercise symptoms and laryngeal outcomes 
in EILO change shortly after IBA plus IMT?  
Research question #10: Does self-reported exercise symptoms after 4-6 years differ 
between EILO patients who only received IBA compared to EILO patients who 
additionally received IMT?  
 
4. Material and Methods 
4.1 Participants 
 
The thesis was based on two groups of participants (Table 5); healthy medical students from 
the Medical Faculty in University of Bergen and patients diagnosed with EILO at the 
outpatient clinic, a cross-professional collaboration between Department of Paediatrics and 
Otolaryngology at Haukeland University Hospital Bergen, Norway.  
Table 5: Overview of the study participants and inclusion  
EILO: Exercise induced laryngeal obstruction; IMT: Inspiratory muscle training; IBA: Information and 
breathing advice (with biofeedback) 
 
4.1.1 Exclusion criteria 
Prior to inclusion, all participants were screened for the following exclusion criteria: self-
reported hypersensitivity to Xylocain® (local anaesthetic used during laryngoscopy) and 
additional lung disease or EIB as explanation for the patient’s symptoms. Exclusion criteria 
for healthy volunteers in Study #I was self-reported history of exercise-related breathing 
problem. Data from the patients that declined to participate in the studies were excluded. In 
Study #II and #III, patients were excluded due to; insufficient data either pre-test or post-test, 
or characteristics of laryngomalacia at rest.  
4.2 Study design 
The four studies were conducted within an explorative approach in a field of medicine not 
previously studied in larger patient groups with objective methods. The design was combined 
descriptive and quasi-experimental observational. 
 
   Study participants Inclusion 
Study #I 20 asymptomatic students Recruited from the University of Bergen 
   
Study #II 28 athletes with EILO 
 
 
Consecutively recruited from the outpatient clinic 2012-
2014, depending on availability of IMT-device 
 
Retrospectively identified from the EILO-register based on 
receiving Supraglottoplasty during 2013-2015 
 
Study #III 45 patients with EILO 
   
Study #IV 55 patients with EILO 
 
Retrospectively identified from the EILO-register based on 
receiving six-weeks of IMT and/or IBA during 2013-2015 
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Study #I (Paper #I)   A cross-sectional study of healthy volunteers.  
Study #II (Paper #II)  A prospective pre-post study of EILO patients  
Study #III (Paper #III) A retrospective pre-post study of EILO patients identified from 
the EILO-register.  
Study #IV (Paper #IV)  A follow-up study of a cohort of conservatively treated EILO 
patients retrospectively identified from the EILO-register.  
4.3 Ethics 
All studies were approved by the Regional Ethics Committee (REK number 2009/2111, 
2011/784 and 2016/1898). Informed written consent was obtained from all participating 
subjects and/or their guardian/parent before inclusion in their respective studies or inclusion 
in the EILO-register. The participants could withdraw their consent at any time. The ethical 
considerations when planning and under conduction of the included studies were based on the 
Declaration of Helsinki [185] and the Norwegian Health Research Act [186]. 
4.4 Sample size 
 
Explorative studies do not have a priori hypotheses (to be tested), but subsidiary hypotheses 
(to be explored), thus calculation of sample size and final number of patients that should be 
included is difficult [187, 188]. One of the main outcomes in the studies (the CLE-scores) is 
relatively new and essential information is insufficient, we especially lack information on the 
distribution, both in patient groups and in healthy. However, previous attempts to calculate 
power before a study on evaluating congenital laryngomalacia compared to healthy controls 
in our group [61], has formed the basis of power assumptions in our studies. Based on “in-
house” experience, we assume that mean CLE sum-score in this patient group is 
approximately 4 and that one standard deviation (SD) would account for approximately 10% 
(0.5) of this mean. The values are based on the scoring system published by Maat and 
colleagues [1]. Thus, 95% of the patients (2SD) would have a total score of about 3 to 5. If the 
intervention leads to a change at group level less than 0.5, it is likely to be of little clinical 
benefit and the intervention will probably be of little value. Therefore, we have considered it 
reasonable to set a lower detection limit to 1 SD (0.5), the significance-level (alfa) to 0.05 and 
beta to 0.2.  
Given this scenario, to detect a difference in CLE sum-score of 0.5 point after an intervention 
using a two-tailed test with an alpha value of 5% and a power of 80%, 16 subjects had to be 
included.  
4.5 Study procedures 
To evaluate changes possibly caused by the treatment, several methods were used to capture 
both laryngeal opening, self-reported symptoms and cardiopulmonary data (Table 6). 
Table 6: Overview of examinations used in Studies #I to #IV 
   Study #I Study #II Study #III Study #IV 
Spirometry at first visit X X X X 
     
Questionnaire 
- At time of diagnosis 
- At time of evaluation after treatment 
- At follow-up 4-6 years after diagnosis 
 
Video-recorded trans-nasal fiberoptic laryngoscopy: 
- At rest with IMT training program 
- During continuous exercise test (CLE-test) 
  
Evaluation of laryngeal responses/obstruction  
- Modified scoring system 

















































   X* 
     
CLE-test: Continuous laryngoscopy exercise-test, CLE-score: grade of laryngeal obstruction by Maat et al [1] 
* The CLE-test are from time of diagnosis and “shortly after IMT” in Study #IV 
4.5.1 Examinations pre-post  
Questionnaire 
 
A questionnaire used in our clinic for several years served to obtain the medical history, 
perceived symptoms, activity level of the patient and the influence of their exercise related 
symptoms on daily life activities (Study #II, #III, #IV). Answers were based on an ordinal 
scale served to grade the severity of symptoms and respiratory complaints during physical 
exertion. All participants (and/or their guardian) completed this at every visit, i.e., before and 
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after treatment. A follow-up questionnaire and a consent form were sent home to all eligible 
patients in Study #IV (Appendix 3).  
Exercise test and lung function measurements 
 
Spirometry was performed in all subjects with a Vmax 22 © spirometer (SensorMedics, 
Yorba Linda, CA, USA) according to guidelines [189].  
A trans-nasal flexible fiberoptic laryngoscope (Olympus ENF-P3©, Tokyo, Japan), diameter 
3.5 mm, introduced after applying a decongestive nasal spray (Rhinox©) and local anesthesia 
(Xylocaine©), was secured using a custom designed helmet in a position allowing for a good 
view of supraglottic structures and the vocal folds in all participants.  
In Study #I continuous video-recorded laryngoscopy was performed at rest during the IMT 
maneuver. In Study #II, #III and #IV, the CLE-test was applied to set the diagnosis of EILO 
and to evaluate treatment. Continuous video-recorded laryngoscopy was performed 
throughout a maximal cardiopulmonary exercise test on a treadmill (Woodway ELG 70, Weil 
am Rhein, Germany) using a computerized and modified Bruce protocol, increasing speed 
and/or elevation every-one minute, aiming to reach maximum exercise capacity after 6-14 
minutes [190]. The set-up was coupled with integrated video-recording of the upper part of 
the body and sound-recordings was performed, as previously described [3] (Figure 6).  
Figure 6: Set up for continuous laryngoscopy exercise-test (CLE-test), 
 as described by Heimdal et al [3].  
The test was considered successful if the patient continued until exhaustion or was stopped by 
respiratory distress, preferably supported by a plateau in oxygen consumption and/or the heart 
rate response. Maximum voluntary ventilation (MVV) and ergospirometry data were collected 
in conjunction with the CLE-test using a Jaeger Oxycon Pro Cardiopulmonary Exercise 
testing system (Viasys Health Care, Yorba Linda, CA, USA). 
Evaluation of laryngeal obstruction 
 
To evaluate the degree of obstruction in the larynx, video-recordings of the larynx was 
assessed retrospectively and in a random order by experienced raters.   
In Study #I the laryngeal movements were scored by an experienced otolaryngologist (J-HH) 
using a pre-set system, modified from Maat and colleagues [1] as all recordings were obtained 
at rest. Laryngeal movements were graded supraglottic and glottic from: maximal abduction 
(+2), moderate abduction (+1), neutral position (0), moderate adduction (−1), and severe 
adduction (−2). Laryngeal adduction has been reported to be a normal phenomenon at end-
inspiration [191]. Therefore, the inspiration was separated into three phases, the initial-, mid, 
and end-inspiration, and only observations from the initial- and mid-inspiratory phases were 
tabulated.  
In Study #II, #III and #IV the scoring system of laryngeal movements previously described 
[1] was applied according to a pre-set scheme (Figure 7). Scores were assigned at moderate 
(i.e. when the test person changed from walking to running) and at maximal exercise intensity 
at glottic (labelled A and C, respectively) and supraglottic (labelled B and D, respectively) 
levels, and additionally a total sum-score labelled E. The diagnosis of EILO was set when the 
patient’s symptoms coincided with laryngeal obstruction graded as 2 or more, either at the 
supraglottic level or glottic level [11, 135].    
The video-recordings were presented in random order to two experienced raters (HHC and 
ODR) in Study #II and #IV, and in pairs (pre-post) to four experienced raters (HHC, ODR, 
MH and JHH) in Study #III. A blinded procedure was tested in Study #III but proved 
impossible, as the surgical changes were impossible to hide. Thus, assessments were open and 
consensus-based, and disagreements were solved by consensus. Clinical symptoms during the 








All patients (and their guardian if present) received information about the diagnosis, its 
benign nature and physician-guided breathing advice (IBA), while observing their laryngeal 
responses on the monitor (biofeedback) at time of their first visit. (Link to web-source 
Figure 7: Grading system of laryngeal obstruction according to Maat et al [1], reprinted with 
permission from European Archives of Oto-Rhino-Laryngology 
https://www.youtube.com/watch?v=jaS0qZN4X9c). The advice consisted of guidance in 
posture, diaphragmatic breathing, and relaxation of the shoulder girdle while illustrating the 
laryngeal response on the monitor. Advice was given to avoid noisy breathing/stridor when 
exercising, to recognize the first signs of breathing problems and to gain control of the 
breathing when these signs arise. All adolescents were encouraged to maintain their desired 
level of physical exercise, and to practice on the breathing advice given during their first visit 
while exercising. 
Inspiratory muscle training  
 
Because of availability of the apparatus and the possibility of two modes of resistance 
(strength and endurance), we used the apparatus Respifit S© (Biegler GmbH, Mauerbach, 
Austria), a flow-resistive loading device, in Study #I, #II and #IV (Figure 8). 
 
The same apparatus was used to measure the maximal inspiratory mouth pressure (Pimax), 
using the best value of ten according to guidelines [192] in order to set correct resistance.  
To promote correct breathing technique during the maneuver, the participants were seated 
with a nose clip and instructed at the first session to inhale using the diaphragm and 
expanding the thorax, and to minimize movements of the shoulders in cranial direction.  
In Study #I we tested two modes of inspiratory muscle training in accordance with the manual 
provided by the manufacturer, i.e.:  
A) Inspiratory muscle strength training (IMST) with the resistance set to produce 
mouth pressures ≥ 80% of Pimax  
Figure 8: Inspiratory muscle training with a resistive loading device (Respifit S©) 
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B) Moderate resistance or inspiratory muscle endurance training (IMET) with the 
resistance set at 60-80% of Pimax.  
In the IMST sessions, subjects performed five maximal inhalations repeated three times, 
separated by a one-minute break. The participants were instructed to exhale passively to 
residual volume (RV), and then inhale from residual volume to total lung capacity (TLC), 
utilizing an appropriate breathing pattern with maximal effort, i.e. a rapid and complete 
inhalation. In the IMET sessions, subjects performed repeated breath cycles with the 
mouthpiece in place, inhaling and exhaling to near RV and TLC using diaphragmatic 
breathing at a rate of 12-16 times per minute for one minute. This was repeated three times 
with 30 seconds breaks in between.  
The frequency and power were guided by an animation program ensuring correct use of the 
device, and data from each training session were stored on a memory-card for measurement of 
compliance with the treatment. 
In Study #II, the same modes of training were instructed, and resistance set after measurement 
of Pimax, and the participants borrowed the apparatus home. They were instructed to train 
every day, in cycles of two days with IMET followed by one day of IMST, for a total of six 
weeks. The same treatment protocol was applied in patients receiving IMT in Study #IV at 
time of diagnosis. 
Supraglottoplasty 
 
All operated patients in Study #III had been informed about the surgical procedure and of risk 
factors. Surgery was performed in general anaesthesia with suspension micro-laryngoscopy 
and endoscopic supraglottoplasty with carbon dioxide laser, as previously described [153]. 
The procedure had been performed by one of two surgeons. The oral laser endotracheal (LET) 
tube was positioned posteriorly, protecting the interarytenoid area. A Lindholm/Benjamin 
laryngoscope was introduced into the vallecular exposing both aryepiglottic folds and 
epiglottis. The arytenoid was grasped with micro laryngeal forceps and pulled slightly 
forward and medially stretching the aryepiglottic fold, revealing the amount of abundant 
arytenoid tissue. Laser beams of 2-4 watt focused with micro spot was utilized. The 
aryepiglottic fold was split anteriorly down to the level of the musculus aryepiglotticus 
approaching the cranial margin of plica ventricularis. Then tissue around the top of the 
cuneiform cartilages was removed in a circular pattern, creating a triangular shaped excision 
(Figure 9). 
  
In cases where the cuneiform tubercles were pointy and exposed in the excision, parts of this 
cartilage were included in the resection. The same procedure was performed bilaterally 
making sure to avoid endothelial damage to the interarytenoid covered by the LET-tube. In 
some cases, with epiglottic involvement, epiglottotomy and rotation of the epiglottis toward 
the tongue base (epiglottopexy) was also performed. Specific anatomic decisions were guided 
by findings on preoperative video-recording during CLE-test and surgery tailored to the 
individual patient’s anatomy [153, 181].  
4.6 Statistical analysis 
 
The statistical analysis in Study #I to #IV are presented in Table 7 and statistical reporting 
was according to SAMPL guidelines [193]. Main outcomes were perceived subjective 
symptoms (obtained by questionnaires) and laryngeal obstruction (CLE-scores or modified 
scores in Study #I). The data were reported as means with 95% confidence intervals (CI) or 
Figure 9: Stepwise description of supraglottoplasty with CO2-laser in EILO patients. A: 
Intubation in trachea, B-C: Cartilages moved medially with micro forceps. Aryepiglottic folds 
divided along the lateral edge of epiglottis. D: The cuneiform and corniculate cartilages are 
removed with laser. E: the procedure performed both sides 
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ranges for continuous normally distributed data and counts with percentages of group-total for 
categorical data, as appropriate. The CLE-scores are by nature ordinal and categorical, 
ranging from 0-3. Due to the few number of categories, data were calculated and reported as 
mean, as this is considered to provide more information than medians and interquartile ranges 
[194]. Missing values were not included in the analyses, the total number included in all 
analysis were stated. The laryngeal scores were tabulated in full in Study #I, a descriptive 
study presented with counts and percentages. In Study #II to #IV, group comparisons were 
performed with Student’s t-test or one-way analysis of variance (ANOVA) for normally 
distributed and Mann-Whitney U test for non-normally distributed, categorical, and 
continuous variables, as appropriate. The distribution of continuous variables was assessed by 
descriptive statistics and histograms, and parametric tests were applied after accounting for 
normal distribution. Sufficient number of observations in the studies justify use of parametric 
significance tests according to the central limit theorem [195]. To account for multiple 
correlated measurements in the same test subject in Study #II and #III, mixed linear 
regression with fixed effects including three- and two-way interactions was applied.  
Only two-sided tests were used and p-values below 0.05 were considered statistically 
significant. All analyses were performed with SPSS version 24 (SPSS, Chicago, IL, USA). 
Table 7. Statistical methods used in Study #I to #IV. 
Statistical methods Study #I Study #II Study #III Study #IV 
Group counts and frequencies x x x x 
Mean and 95% confidence intervals  x x x 
Student’s t-test  x x         x 
Mixed linear regression  x x  
Analysis of variance (ANOVA)    x 
5. Summary of results 
5.1 Paper #I (Study #I):   
Laryngeal movements during inspiratory muscle training in healthy subjects 
Twenty healthy volunteers completed a training program with IMT (Respifit S©) with 
continuous laryngoscopy for visualization of the laryngeal response. We found that IMT can 
facilitate laryngeal abduction in healthy subjects, substantiating the PCA/diaphragm 
relationship [45]. However, a relatively large inter individual variability among the laryngeal 
response patterns during IMT was observed (Figure 10).  
 
The laryngeal response pattern to the muscular strength program (IMST) with resistance ≥ 
80% of Pimax, differed from that of the muscular endurance program (IMET) with resistance 
between 60-80% of Pimax. During IMST, only six (32%) of the 19 subjects achieved maximal 
abduction of the laryngeal inlet throughout the complete inspiratory phase, four subjects had a 
moderate abduction. In two subjects, a moderate adduction was observed in the initial phase, 
one of whom developed a severe laryngeal adduction mid-inspiration, initiated by the vocal 
folds (glottic level), and followed by supraglottic structures. When lowering the resistance in 
the IMET program, laryngeal abduction was observed in 18 (90%) of 20 subjects. In the 
Figure 10: Examples of laryngeal response patterns during IMST in healthy volunteers [2], reprinted 
with permission from Journal of Voice 
Abbreviations: TVF: true vocal folds; AEF: aryepiglottic folds; CT: cuneiform tubercle 
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remaining two (10%) subjects, the larynx initially adopted a neutral position, followed by a 
moderate adduction in mid-inspiration in one of them. The findings underline the complexity 
of larynx, with muscles working together in a complex and coordinated way.  
In conclusion, laryngoscopy provided visual confirmation of the relationship between the 
diaphragm and the PCA-muscle by visualization of laryngeal abduction during IMT in 
healthy subjects (Research question #1). Both IMST and IMET increased the laryngeal 
aperture in healthy subjects, but the application of medium resistance (IMET) seems superior 
to higher resistance (IMST) to achieve the desirable abductive response in all. (Research 
question #2 and #3). The findings are encouraging in terms of IMT as a treatment option for 
EILO and warrants further studies.  
5.2 Paper #II (Study #II):  
Exercise-induced laryngeal obstruction in athletes treated with inspiratory muscle training 
Thirty athletes diagnosed with EILO completed a six-week training program with IMT, two 
were excluded due to insufficient datasets. Symptom improvement was reported in the 
majority. After IMT, 22/28 (79%) responded yes to a question if they felt their EILO problem 
had improved, whereas one reported that symptoms had worsen; 12/28 (43%) athletes 
responded nothing or a bit to the question “How much are you bothered by your breathing 
difficulties?”. At exercise-testing after IMT, 5/28 (18%) athletes had an open larynx at 
maximum exercise intensity (CLE-sum scores 0 or 1). In 23/28 (82%) athletes, the CLE-sum 
scores improved, 8 of whom had a decrease in CLE-sum score ≥2, whereas 3/28 were 
unchanged. In two athletes, the CLE-sum score worsened, of whom one was judged by both 
raters as a classical supraglottic EILO and the other as a typical fast onset glottic EILO, 
characterized by anxiety and panic. A significant difference (before versus after) using mixed 
linear regression was observed only at maximal exercise intensity at the glottic laryngeal level 
(Figure 11).  
In conclusion, perceived exercise induced symptoms and the laryngeal closure improved in 
most patients after IMT (Research question #4 and #5). Laryngeal improvements were seen 
mainly at the glottic level, suggesting that IMT might contribute to better control of 
particularly the vocal fold movements. We hypothesize that IMT may become an efficient 
conservative treatment tool in subgroups of EILO, and that one should probably be careful 
when applying IMT in predominant supraglottic EILO. The findings warrant for future 
randomized controlled trials that are needed to establish the scientific evidence of effect of 
IMT in EILO patients. 
 
5.3 Paper #III (Study #III):  
Severe exercise-induced laryngeal obstruction treated with supraglottoplasty 
Sixty-one patients with severe supraglottic EILO were treated with supraglottoplasty during 
2013-2015, twelve were excluded due to insufficient datasets and four excluded due to 
characteristics of laryngomalacia at rest. Thus, 45 were included in this retrospective study. 
Laryngoscopy at rest was normal in all subjects. After surgery, perceived subjective 
symptoms had improved in 38/44 (86%, one answer missing) and were unchanged in 5/44 
(11%). All patients had significantly lower CLE sum-score after surgery, group mean reduced 
from 5.38 to 2.36; most improvements explained by reduced supraglottic scores at maximum 
exercise (CLE D-score) as expected (Figure 12). However, in 21/45 also the glottic 
obstruction decreased at maximum intensity exercise. 
Figure 11: Laryngeal obstruction scores according to Maat et al [1] in patients with EILO before and 





The CLE sum-score was reduced by 2 or more in 38/45 (84%) patients. There were no signs 
of laryngeal obstruction at maximum exercise intensity, i.e. CLE sum-score 0 or 1 in 16/45 
(36%). Complication rate in our data was 3% (2/65); a left vocal fold paresis that 
spontaneously resolved three years later and one with post-operative scarring with no 
symptoms at rest but breathing symptoms during exercise [196].  
  
In conclusion, supraglottoplasty appears as a safe treatment for highly selected severe 
supraglottic EILO patients (Research question #6). Symptoms and laryngeal obstruction 
improved in the investigated patients after supraglottoplasty (Research question #7 and #8). 
Notably, supraglottoplasty might also improve glottic obstruction in patients with combined 
supraglottic and glottic obstruction. Risk of complications calls for careful selection of 
patients based on a multidisciplinary approach, thorough evaluation of the laryngeal 
obstruction (EILO subgroup) and with conservative treatment tested prior to surgery. 
5.4 Paper #IV (Study #IV):  
Clinical responses following inspiratory muscle training in exercise induced laryngeal 
obstruction 
 
Altogether, 116 participants were identified from the EILO-register, response rates after 4-6 
years were 23/58 (40%) and 32/58 (55%) in the IBA and IBA+IMT-group, respectively. At 
Figure 12: Laryngeal obstruction scores according to Maat et al [1] in patients with EILO before  
and after supraglottoplasty, reprinted with permission from Frontiers in Surgery. 
 
diagnosis, both groups rated symptoms similarly, but laryngeal scores were higher in the 
IBA+IMT-group. Shortly after IBA plus six weeks of IMT, 23/32 reported symptom 
improvements, associated with laryngeal improved, particularly with glottic changes (scores 
1.7 vs. 0.3; p<0.001), contrasting unchanged laryngeal scores in 9/32 without symptom 
improvements (Figure 13).  
 
 
Following 4-6 years after diagnosis, exercise-related symptoms had improved, and activity 
level had decreased to similar levels in both groups irrespective of laryngeal findings and 
symptom reports shortly after IMT. Full symptom resolution was rare, only reported by 8/55 
participants. Respiratory symptoms still disturbed most participants during exercise.  
In conclusion, self-reported exercise symptoms and laryngeal outcome had improved shortly 
after IBA plus IMT, with EILO symptom improvements associated with glottic improvements 
(Research question #9). After 4-6 years, self-reported exercise symptoms had improved in 
both groups irrespective of initial treatment (Research question #10).  
Figure 13: Laryngeal obstruction (evaluated by CLE-scores at glottic and supraglottic level) in 
subjects with EILO before and after treatment with IBA plus six weeks of IMT. P values refer to mean 





The first part of the discussion will focus on the methodological aspects. Thereafter clinical 
implications of EILO, a general discussion of the main findings and suggestions for future 
research will follow. 
6.1 Methodological considerations, strengths and limitations 
 
To the best of our knowledge, this is the first thesis addressing evaluation of different 
treatment modalities in EILO patients in a short- and long-term perspective. Through clinical 
work and studies with an explorative nature, we have gained knowledge that will serve as a 
necessary basis for future controlled treatment trials. The strengths of this study was firstly 
that all patients were diagnosed with what is considered gold standard for diagnosing EILO, 
the CLE-test [79]. The same outcome measures were obtained under standardized conditions 
and applied in all the studies upon which this thesis is built, i.e., both subjective (self-reported 
symptoms) and objective (video-recordings of laryngeal response patterns) outcomes before 
and after treatment. The results were all stored in patients’ charts, making the results available 
for later validation. The laryngeal obstruction was evaluated at both supraglottic and glottic 
level according to a pre-set scheme by experienced raters in a blinded procedure when 
possible. Recruitment of patients from the EILO-register in Study #III and #IV made it 
possible to include eligible participants from a heterogeneous patient population, and to 
conduct research on “real life patients” as they appear on a daily basis in clinical work, 
facilitating the generalizability of the findings. Finally, investigations of response patterns to 
different treatment modalities in EILO patients irrespective of subgroup or phenotype in an 
explorative and descriptive manner, is considered a strength as we do not properly understand 
to what extent different subgroups constitute separate disease entities or if they represent 
variations of one disease [118]. Thus, potential improvement from treatment in one EILO 
subgroup might be obscured by lack of improvement in another, and true effects may be 
concealed or difficult to detect.  
However, the included studies also have limitations. Firstly, one large obstacle in EILO 
research, and thus also seen in our work, is that the correlation between perception of 
symptoms, the observed symptom presentation and the degree of laryngeal obstruction is 
likely individual and has not been properly established [79]. The studies that constitute the 
basis for this thesis includes a number of participants exceeding most previous research on 
EILO. Nevertheless, in order to establish solid data on the investigated issues, more patients 
need to be included in future studies. The pre-post study design without randomization before 
treatment and lack of control groups in Study #II and #III, are obvious weaknesses when 
evaluating treatment modalities. As with all small non-randomized un-controlled studies, the 
findings must therefore be cautiously interpreted. To some extent this uncertainty was 
compensated by the convenience-based and unbiased allocation to IMT in Study #II and #IV 
and the same thorough objective evaluation before and after treatment in Study #II, #III and 
#IV, making each participant serve as “their own control”. A potential bias was that two 
different surgeons performed the supraglottoplasty procedure in Study #III, and that the IMT 
and IBA instructions were provided by three different physicians whose consistency was not 
established. However, these physicians know each other well, and they work together daily in 
a coordinated and standardized manner. Finally, a validated questionnaire to aid the self-
reported symptoms would have been preferable, but this did not exist at the time the included 
participants were diagnosed (2013-2015) [79].  
These issues regarding validity and reliability will be further discussed below. 
6.1.1 Subjects and study sample 
 
External validity describes the extent to which the results of a study can be generalized to 
others with the same condition [197]. The question is whether the results from the small 
groups examined can be generalized to the background population of all EILO patients. The 
study was conducted at the outpatient clinic in Bergen, receiving patients from all over 
Norway and is one of the centres in the world that has conducted most EILO examinations by 
date. The patients in Study #II were prospectively recruited from the clinic. In Study #III and 
#IV the patients were selected retrospectively by consecutive inclusions from a nationwide 
EILO-register. We acknowledge that a population derived from a tertiary centre might 
represent a potential referral bias, with patients with more severe symptoms or who are more 
“eager” to be investigated and treated. By nature, patients with EILO who reduce their 
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activity level and thereby also reduce their symptoms, do not seek health care. Given these 
considerations, we conclude that recruitment from our outpatient clinic is considered 
representative for the EILO population who seeks treatment, as they are described in the 
literature with participants of all levels of exercise capacities [94, 198].  
Our test sample seems representative of the EILO population regarding age [4, 11, 30-32]. 
The age distribution of healthy volunteers in Study #I (mean age: 24, range 21–29 years) was 
higher than mean age of the participants in Study #II and #III, possibly questioning the 
relevance for the age group in which EILO is most prevalent. However, all the examined 
volunteers had a normal larynx and no history of exercise induced inspiratory symptoms 
(EIIS), and therefore constituted a representative sample to investigate normal laryngeal 
response to IMT in a fully developed larynx. The laryngeal structures become more rigid with 
age [27, 199] and whether the larynx responds differently in different ages is unknown. One 
may speculate that a younger study population would have generated even more 
heterogeneous response than we found.  
Regarding the gender distribution, there was a female predominance in all the included 
studies, and more so among those treated with second-line therapy (Study #II and #IV) than 
what has been described in the literature [30]. The reason for a possible female predominance 
in EILO patients is described in section 1.2.2, but one may question if males are 
underrepresented in referral for CLE-testing. The well described female tendency to report 
higher symptom scores in health-surveys [200] might contribute to more females being 
considered for second-line therapy (IMT). 
To conclude on these issues, we hold that our recruited patient populations were 
representative for EILO patients who choose to seek treatment, and also comparable to 
patients described by others in the literature [30, 32, 198].  
6.1.2 Sample size 
 
Internal validity may be defined as a study’s ability to measure what it set out to measure, and 
one must consider sources of error that might provide an alternative explanation for the 
findings; random errors, bias and confounding [201]. Adequate sample size is important to 
reduce risk of random error, explained as the variability of the data that cannot easily be 
explained [201]. Sample sizes in clinical studies depend on the availability of consenting 
participants. Due to few IMT apparatuses available and a training-period of 6-8 weeks, 51 
patients underwent this treatment over a period of 2 years in Study #II. Not all participants 
were compliant to the training, and some did not want to perform a post-CLE-test. The 
patients completing the IMT protocol also formed the basis for the sample in Study #IV. The 
clinical data in Study #III were recorded retrospectively, and there were in some cases 
insufficiencies in the registration of data or technical problems with the video-recordings. 
Despite reminders we were unable to achieve a higher response-rate in Study #IV, and low 
response rates will of course introduce an unknown risk of responder bias due to a possible 
overrepresentation of adolescents with persistent experience of exercise-induced dyspnea. On 
the other hand, there might be patients who were so satisfied and happy with their treatment 
that they wished to provide feedback to the institution that helped solve their breathing 
problem. The characteristics regarding age, sex, symptom scores and CLE-scores did not 
differ between non-responders and participants at the time of diagnosis, but we had no way of 
establishing the motivation for participating at follow-up. The response rate is in line with 
some [202] but lower than other follow-up studies after treatment of EILO patients [144, 152, 
155].  
The low numbers complicated the statistical handling of the data, making the study vulnerable 
for particularly type II-errors; i.e., failure to detect significant differences that may have been 
present [187]. We therefore chose to provide descriptive reports of individual differences 
behind group means, in order to demonstrate the heterogeneity of the laryngeal responses and 
the patient group itself. We considered this a strength in this context. Confidence intervals 
were presented for all mean values, to address the issue of uncertainties [187]. A priori power 
calculations were difficult to perform as we did not know the distribution of the variables 
under investigation in this unstudied research field. There were some uncertainties with regard 
to the calculations performed with the CLE-scores being used as outcome measure (see 
Methods section), however the calculations suggest that adequate numbers of participants 
were included in Study #II and #III. Having said this, Study #II, #III and #IV still represent 
the largest patient series of their kind in the literature.  
6.1.3 Study design 
 
The knowledge on treatment modalities, especially conservative measures, in EILO patients 
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were sparse and a descriptive explorative approach (or qvasi experimental design) was 
chosen. Thus, we prepared research questions to be explored rather than null hypotheses to be 
tested.  
Cross-sectional study design (Study#I and #III) 
 
A cross-sectional study design was used to document the status at a single time point or over a 
short period of time for each participant. The healthy volunteers in Study #I were only 
examined at one time point, acknowledging that the results obtained might differ from results 
obtained at another time point due to unrecognized confounders [203]. The definition cross-
sectional pre-post study in Study #III may be discussed, as we evaluated two different 
examinations (over a short period of time), and in hindsight, a better term might have been 
“Retrospective pre-post study”.  
Pre-post study design (Study#II and #III) 
 
In a pre-post study design, outcome(s) are measured before and after an intervention [204]. As 
each patient served as his/her own control, the method has the strength of temporality and to 
suggest that the outcome is impacted by the treatment. However, pre-post studies do not 
control other elements (confounders) that are also changing at the same time as the 
implemented treatment. Factors that might come into play and influence outcome are for 
example conditioning, or the effect itself of being tested and/or receiving a diagnosis and/or 
receiving a treatment, or by the simple fact that the participants take part in a study (the 
Hawthorne effect) [205]. Therefore, changes in relation to symptoms and laryngeal 
obstruction cannot be uncritically attributed to the intervention (IMT or supraglottoplasty). 
From a research perspective, the preferred design for evaluating effect of treatment is a 
randomized control trial [206]. A control group and formal randomization in Study #II and 
#III would clearly have strengthened the internal validity of the study by reducing risk of 
selection bias and confounders [203]. However, to set up a controlled study in the previously 
described “uncharted territory” of EILO treatment was not possible at the time the work 
leading to this thesis was commenced.  
Retrospective identification from the EILO-register (Study #III and #IV)  
 
Register-based studies are particularly suitable for investigating heterogeneous populations if 
the cover ratio is good [206], since they have broader inclusion criteria and fewer exclusion 
criteria. The EILO-register consists of patients diagnosed with EILO at Haukeland University 
Hospital after 2013. All participants in Study #III and #IV were recruited from this registry, 
thus reducing the risk of selection bias. A disadvantage of register-based studies is that both 
reporting from the patients and the clinicians are subject to bias [206], which we acknowledge 
and have tried to account for by using pre-set schemes in the clinical work. With retrospective 
follow-up studies there is a risk of bias by recall or in terms of positive and negative 
expectations related to the development of symptoms over time. This mechanism may have 
been involved in the IBA+IMT-group in Study #IV, where the significance of the breathing 
problem was scored lower when asked at diagnosis, compared to when retrospectively 
confronted with the same question at follow-up. 
6.1.4 Outcome measures 
 
Validity and reliability indicate how well a test measures an outcome. Reliability and 
repeatability are concepts that may be used interchangeable, and refers to the overall 
consistency of a measure [197, 207]. Validity refers to the ability of a test to measure what it 
is meant to measure [208]. The results of this thesis were based on application of both 
subjective rating (by the same questionnaires) of self-reported symptoms and a more objective 
evaluation of laryngeal obstruction (by CLE-scores) before and after treatment. 
Self-reported symptoms 
 
Self-reporting of symptoms may be questioned with respect to validity, as a fundamental 
shortcoming of all subjective approaches is the potential for misinterpretation of the questions 
or the potential of over- or understatements or socially desirable responding [200]; both by an 
“eager to please” mechanism or by an unrealistic expectation of effect from the treatment. 
Dyspnea is complex and by nature a subjective feeling [99], and the subjective perception of 
exercise symptoms also reflect real-life influence and how the patients cope with their 
breathing problem [101]. Therefore, such factors are probably important when self-reported 
symptoms are used in evaluating treatment responses in EILO. Validated questions that can 
be used to quantify self-reported symptoms of EILO are currently an unmet need in this 
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research field [158], and certainly was at the beginning of this study [79]. Still no validated 
questionnaire exists in Norwegian. When this is said, the questionnaire applied has been 
utilized for many years at our clinic and addresses domains of sensory-perceptual experience 
and symptom impact or burden, as recommended when assessing dyspnea [101]. Six of the 
questions on symptoms are later validated in a context of monitoring and measuring 
symptoms of EILO [115]. Key items were retrieved from other respiratory contexts [117], and 
the questions are similar to questions applied in other studies [152, 155]. To be able to address 
longitudinal development, we applied the same questions at follow-up as were applied at 
diagnosis in Study #IV. Ideally, patients in Study #IV should have performed a new CLE-test 
at follow-up since poor physical condition is a common cause of dyspnea in studies that 
record symptoms from questionnaires [98, 102], and cannot be ruled out as a cause of 
respiratory complaints reported at follow-up in this study.  
Symptom-presentation evaluated by an observer is reported to correspond well with the 
severity of laryngeal obstruction (CLE-score) [1], but perception of breathlessness is 
individual with a wide range of factors potentially contributing [91, 97] and does not 
necessarily correlate to the degree of obstruction [90, 120]. The pre-post CLE-test set-up 
allows for a more objective evaluation of the influence of the treatment, but the subjective 
self-reported symptoms convey the real-life benefits and must therefore be considered. 
Therefore, the strategy of reporting outcomes as self-reported symptoms combined with the 
CLE-test changes, enhances the validity of the results of the studies included in this thesis.  
Laryngeal obstruction (the CLE-score) 
 
Interobserver reliability addresses if a test provides the same results regardless of who carries 
out the measurement, and intra-observer reliability addresses if a test provides the same 
results when assessed twice or more by the same observer given that what we are measuring 
is not changing [197, 207]. The CLE-scoring system has been found reliable and valid to 
evaluate laryngeal function during exercise, with adequate inter-observer and intra-observer 
reliability of scores [1, 94]. A small study by Mirza and colleagues, found substantial 
agreement in supraglottic scores, but moderate agreement on glottic scores between two tests 
[94]. However, the scoring system has also been criticized for not classifying the severity of 
EILO in a reliable and robust way [135, 209]. The video-recordings are objective and stored 
for repeated evaluation, but the visual grading of the laryngeal obstruction is at risk of bias, 
because of the subjective evaluation by the rater. Visual grading of images is seen also in 
other fields of medicine, e.g., measurement of the ejection fraction in heart ultrasound [210]. 
Our research group has tried to solve some of these problems by using experienced raters 
from different professionals to evaluate the video-recordings, and to settle disagreements by 
consensus, as experience among the raters influence reliability [197, 207]. The raters of the 
CLE-tests were blinded in Study #I, #II and #IV to account for observer-bias.  
To evaluate the degree of laryngeal obstruction from the two-dimensional view obtained from 
endoscopy is challenging. It is important to keep in mind that CLE scores only rate the 
relative degree of adduction of laryngeal structures. If the absolute size of the laryngeal 
aperture varies between people, this “relative approach” might be misleading as a similar 
degree of adduction might have different functional consequences in different people. 
Therefore, in our research group’s opinion, it is important to evaluate the development of the 
process that eventually leads to laryngeal obstruction and evaluate each larynx individually, as 
the point where increasing laryngeal obstruction becomes critical in terms of creating 
symptoms, is likely to differ between individuals, and – importantly – this point has not yet 
been established (Figure 4).  
Concluding on these issues, it seems correct to state that the CLE-scoring system must 
currently serve as “the best available” method to rate the outcomes from a CLE-test, and that 
it provides a semi-objective outcome measure for evaluating laryngeal obstruction. It is 
important to apply the scoring system with caution, being aware of its shortcomings that could 
bias the assessment of treatment outcomes [135]. Development of a better scoring system is 
pending, both for diagnosis and evaluation of treatment, and was highlighted as a major 
research priority in the recent ERS/ELS statement [79].  
The CLE-test and the test conditions 
 
The CLE-score is based on video-recordings obtained from the CLE-test. Intra-subject 
reliability addresses if a test provides the same results if carried out twice or more in the same 
subject under the same conditions [197, 207]. It is important to reduce the factors that may 
contribute to the variability of measures like patient motivation, patient instructions, testing 
procedures, equipment/calibration errors and change in physical activity level.  
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The integrated testing system (CLE and full ergospirometry) with a computerized protocol 
was run according to manuals and was calibrated every morning and immediately before each 
test. Every test was performed under the same environmental conditions, with the same 
technician responsible for the test to be performed according to the standardized procedure. 
During the test, the technician pushed the participants to their limit of exercise tolerance. The 
applied computerized exercise-test protocol, consisting of gradual increases of both speed and 
angle from a slow flat initial walking phase, was considered satisfactory, as the participants 
ranged from sedentary individuals to top athletes. Treadmill exercise was preferred to cycle 
ergometer, as walking and running are familiar to most people. We used the same 
standardized protocol in all participants. However, some individuals may not be able to elicit 
their EILO symptoms due to the nature of their sport is different from a conventional 
treadmill test. One may speculate if individualized protocols would be more expedient, but at 
least the same protocol should be applied before and after treatment for adequate comparison. 
The influence of a laboratory setting versus “in the field” testing calls for exploration in future 
studies and has already been tested with rowing and swimming [50, 120]. 
A possible training effect of performing a second CLE-test could in theory have influenced 
the results as stated by Walsted and colleagues [135]. It is not our research group’s clinical 
experience that performing a CLE-test itself improves EILO and this has not been observed 
among patients performing multiple CLE-tests at our department (data not presented). To the 
best of our knowledge, the EILO literature does not suggest this either. Changes between tests 
in our studies were only significant for the variable “time to exhaustion”, which increased by 
a mean of 30 seconds from the first to the second test (data not tabulated). One may interpret 
this tendency for increased persistence at the second test as a risk of under-detection of EILO 
in the first test, i.e., not exercising long enough to achieve the exercise level when symptoms 
appear. Nevertheless, our findings are not based on the duration of the test but on comparisons 
of the laryngeal obstruction before and after at the same exercise intensity (compared by 
cardiopulmonary values), and not as isolated events. When this is said, the intra-subject 
reliability of the CLE-test needs to be established for future research [79].   
Confounders such as change in physical activity level or the health condition of the subjects 
between the exercise tests (before and after treatment) may influence the results and lead to 
bias. A spirometry was conducted before each test to ensure that there was no airway 
obstruction to interfere with the results. If the patient was ill within the last 14 days, the test 
was postponed. In Study #III, where mean follow-up time varied, the aforementioned factors 
were impossible to eliminate completely, an obvious weakness of the study. However, 
ergospirometry performed in all made it possible to compare each larynx at the same exercise 
intensity and to ensure that the degree of exhaustion in both tests were adequate and similar in 
each subject to reduce some of these uncertainties. Additionally, the ergospirometry test made 
it possible to evaluate the self-reported physical activity level as self-reported instruments 
tend to overestimate the intensity and duration of physical activity [200].  
6.2  Clinical implications and health consequences of EILO 
 
Individuals ultimately diagnosed with EILO have often initially been misdiagnosed as 
exercise induced bronchoconstriction (EIB) [103, 104, 110], which presumably has resulted in 
mismanagement for long periods [108, 109]. In general, misdiagnosis and mismanagement of 
EILO may lead to patients’ unnecessary seeking for health care and thus the generation of 
unnecessary costs, unnecessary investigations, and unnecessary medications with potential for 
unfortunate side effects [14, 162, 211]. EILO in athletes may lead to emotional stress, and 
over time prevent athletes from meeting the demands of their athletic participation [91, 157]. 
Dyspnea during exercise may also make young people reduce their level of physical activity 
and/or make them terminate their sports participation in an effort to minimize the frequency 
and severity of their breathing problem [147], a well described phenomenon in adolescents 
with EIB [104]. In a group with undiagnosed respiratory symptoms in subjects 12-14 years of 
age, 25% reported activity limitations [212]. Subjects with undiagnosed respiratory symptoms 
have reported more absence from school and low health-related quality of life compared to 
healthy peers [213].  
Factors that affect physical activity are multifactorial, but young people moving from High 
School to college are at risk of inactivity and weight gain [214, 215]. The age period crucial in 
relation to the debut of EILO is also a vulnerable period for reduction in activity level, as 
many adolescents drop out of organized sporting activities [216]. The outcome and health 
gain of staying physically active, is substantial and strongly advocated, as well as important in 
a social context [214]. In Study #IV, most participants reported to have reduced their level of 
physical activity 4-6 years after diagnosis. Respiratory symptoms still disturbed most 
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participants during exercise, however, fortunately the minority reported that their breathing 
problem prevented them from exercising.   
Given the high prevalence of EILO, proper handling and follow-up of these young individuals 
seems important also from a public health perspective, as it might contribute to maintenance 
of a healthy level of physical activity [214, 217]. Although EILO symptoms usually ends 
when exercise is stopped, the desired outcome of our endeavours ought to be that breathing 
problems should not prevent adolescent from exercising. 
6.3 Discussion of the main findings of the study 
 
The present thesis demonstrates the complexity of the larynx, with large heterogeneities in 
response patterns to high intensity exercise, both before, during and after the applied 
treatment modalities in both asymptomatic volunteers and EILO patients. Our results indicate 
that both supraglottoplasty, inspiratory muscle training (IMT) and structured information with 
breathing advice (IBA) can improve symptoms and the laryngeal obstruction in short and long 
term in the majority of patients, with outliers in both directions.  
To the best of our knowledge, we are the first to investigate the theoretical basis of applying 
IMT in EILO patients, by visualisation of the PCA/diaphragm relationship [21, 37, 39, 45] in 
Study #I. IMT enhanced the laryngeal opening during inspiration at rest in healthy volunteers. 
However, application of medium resistance seemed to be superior to higher resistance, as the 
former led to the desired laryngeal abduction in almost all participants. IMT in EILO patients 
reduced symptoms and laryngeal obstruction during high intensity exercise, with 
improvements seen mainly at the glottic level.  
For EILO patients with severe supraglottic obstruction, supraglottoplasty is considered a safe 
procedure that reduces symptoms and laryngeal obstruction (as expected) at the supraglottic 
level. Interestingly, findings in Study #II and #III indicate that IMT also can be beneficial for 
supraglottic EILO (if not too severe), and that supraglottoplasty also can be beneficial for 
combined supraglottic and glottic EILO, with significant improvement observed also at the 
glottic level after surgery. Study #IV is the first long-term follow-up study after IMT used to 
treat EILO. Self-reported exercise-related symptoms were significantly reduced at follow-up 
4-6 years after diagnosis and treatment with IMT and/or IBA. Symptom-scores at follow-up 
did not differ between those treated with IBA only and those who had additional six weeks of 
IMT. However, full resolution of breathing problems was rare. 
The studies included in this thesis generate hypotheses of which treatment modality may be 
beneficial for different EILO subgroups. The findings substantiate the importance of 
classifying the level of obstruction as well as emphasizing the importance of proper 
evaluation after treatment and adequate follow-up to uncover persisting symptoms. What 
structures incites and perpetuates the pathology of a malfunctioning larynx, together with 
patient motivation, seems important when selecting treatment modality. The knowledge 
provided should be tested by others in randomized controlled studies. 
6.3.1  Diversity of findings in EILO patients 
 
In all examined participants, the larynx appeared normal at rest, but a large heterogeneity of 
laryngeal responses to exercise and treatment measures was observed. As seen in previous 
reports using the CLE-test [11, 107, 198], the most common EILO subgroup was supraglottic 
obstruction in a moderate degree as an inciting event, with adduction of the vocal folds 
appearing as a consequence or an associated phenomenon. Other subgroups were severe 
supraglottic obstruction with flaccid tissue without (or only minor) adduction of vocal folds. 
A few cases presented with primary adduction of the vocal folds as the major inciting event, 
with or without panic reactions. In some cases, the contribution of epiglottis to the sequence 
of events was probably important, based on clinical/empirical evaluation, but difficult to 
quantify as it is not involved in the scoring system applied [1]. Likely, there is also a floating 
clinical transition between the EILO subgroups. All of which seems important in development 
of treatment modalities tailored to subgroups.  
Clinical symptom presentation and the degree of laryngeal obstruction seem to progress in a 
continuum, but to define a distinct cut-off for where the obstruction begins and the response 
ceases to be normal, is still challenging [207]. The findings throughout this thesis reveal inter-
individual differences both in symptom perception and the laryngeal findings, as 
demonstrated in Study #IV were rating of symptoms were similar in both groups despite more 
advance laryngeal obstruction in the IBA+IMT group at time of diagnosis, thus supporting the 
notion of individual differences in relation to perception of when ventilation is limiting 
(Figure 4). However, the reported subjective improvement shortly after IMT in Study #IV was 
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associated with laryngeal changes, especially at the glottic level. An impression after 
conducting the studies of this thesis, is that the level of physical activity and how the patients 
deal with their breathing problem also seem to be of relevance for the subjective rating of the 
symptoms.  
Based on the experience obtained from conducting the work that this thesis is based on, and 
the heterogeneity that we have observed regarding the laryngeal response to high intensity 
exercise, caution is advocated when future studies are planned to evaluate treatment 
modalities in EILO patients. 
6.3.2 Inspiratory muscle training 
 
The symptomatic improvement after IMT seen in Study #II and #IV was consistent with 
previously published case-reports [147-149], and the findings substantiates the hypothesis that 
IMT targets glottic obstruction better than supraglottic obstruction in EILO patients. 
Specificity of IMT 
 
The laryngeal response to IMT in healthy normal individuals needed to be investigated in 
before applying IMT in EILO patients in subsequent studies. Study #I showed that IMT did in 
fact facilitate laryngeal abduction among the participants. The effect was poorer, and in some 
individuals even counterproductive, when applying high (≥80% of Pimax) compared to lower 
resistances. Different response patterns seen during different inspiratory loads in Study #I is 
consistent with findings of high level of inherent biological variation in the structures of the 
upper airway in an MRI study [169]. The findings emphasize that opening of the laryngeal 
aperture can be more a question of training coordination, rather than the strength of the 
muscles. This phenomenon is consistent with training of skeletal muscles, i.e., that strength 
performance depends not only on the quantity and quality of the involved muscles, but also on 
the ability of the nervous system to appropriately activate specific movements and to better 
coordinate the activation of all relevant muscles [218, 219]. Thus, targeting the correct 
breathing technique with co-ordination of the inspiratory muscles seems crucial for effect of 
IMT in EILO patients and perhaps instructions with the laryngoscope in place could assist in 
achieving the wanted response.  
Specificity of training in general implies that the training response/adaptations are tightly 
coupled with the nature of the applied stimulus [165, 220]. In short, muscles tend to respond 
to strength training stimuli (high intensity and short duration) by improving strength and to 
endurance-training stimuli (low intensity and long duration) by improving endurance [65, 
218, 219]. In EILO patients, modalities that lead to laryngeal abduction and enhanced 
laryngeal patency seems preferable, and IMT may be beneficial both in enhancement of 
muscular strength and as a learning effect on co-ordination of inspiratory muscles leading to a 
more desirable breathing pattern. Thus, it seems reasonable to advocate a combined training 
program with elements of both endurance training (IMET) and strength training (IMST), 
contrary to only high-intensity training as applied in most published cases [147, 148]. 
However, concurrent training regimen (both strength and endurance training) may be sub-
optimal because of targeting different specific adaptations [165], a phenomenon well 
established for peripheral skeletal muscles [221], and might also be the case with the 
inspiratory laryngeal muscles which may have influenced the outcome in Study #II and #IV.  
The subjective and objective responses to IMT varied in Study #II and #IV. One may 
speculate if this was due to inclusion independent of EILO subgroups or that the patients that 
do not report symptomatic improvement shortly after IMT might be unable to engage the 
targeted inspiratory laryngeal muscle group, as seen in a few subjects in Study #I. Also, a 
potential concern when enhancing the ability of the diaphragm and inspiratory accessory 
muscles, is that the larynx remains the critical restriction of ventilatory capacity, i.e., “the 
bottleneck of the airways”. If the strength of the inspiratory muscles is enhanced by IMT, this 
might conceivably lead to increased inspiratory airflow and therefore increased intraluminal 
negative pressure in the larynx (the Bernoulli phenomenon) [54]. By this mechanism, flaccid 
supraglottic structures might get sucked inwards to a greater extent, which may lead to a 
posterior redirection of airflow and more turbulence, with alterations potentially influencing 
the intraluminal pressure also further down in the glottic area. In one of the patients with 
supraglottic obstruction worsening after IMT in Study #II, we could see that the redundant 
supraglottic tissue was adducted to a more severe degree during inspiration after IMT. One 
may therefore speculate if IMT may cause more harm than benefit in some cases of 
supraglottic EILO. We hypothesize that subgrouping EILO, would be a feasible approach in 
future studies addressing IMT to treat EILO patients.  
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IMT protocol (modality, resistance, frequency and duration) 
 
Studies assessing IMT in EILO are scarce, and no standardized IMT protocol exist. The 
literature is also inconsistent in use of training modes, pressure settings, duration and number 
of repetitions for IMT protocols in healthy athletes [49, 221]. There are multiple possibilities 
regarding different devices, resistance loads, frequency etc. The breathing resistance applied 
in Study #I, #II and #IV were of flow-resistive loading, and the findings from these studies 
can not necessarily be transferred to other devices or other modes. Isokinetic training over 
threshold-training seems logical when targeting breathing technique, however, this is not 
scientifically verified. A training period of six-weeks has shown a plateau in inspiratory 
muscle strength and power [218], thus, the length of training chosen in our studies.  
The resistance applied in the published case-reports on IMT and EILO varied from 25 to 80% 
of Pimax [147-150]. A load set to 50% of Pimax is known to improve thoracic inspiratory 
muscle function in healthy subjects [218], whereas optimal resistance in that respect is 
reported to be 60%-80% of Pimax, declining at higher and lower intensities [67]. As little 
evidence on IMT and EILO existed before embarking on the included studies, we chose to use 
resistances as suggested by the manufacturer with an inspiratory load of Pimax ≥80% in the 
IMST program, and 60-80% of Pimax in the IMET program, and to explore both IMST and 
IMET as previously mentioned. The equipment used, Respifit S®, is expensive and we could 
have chosen cheaper alternatives. However, availability and experience from our department 
made this the most convenient choice. In addition, the apparatus had a memory card to check 
for compliance of training.  
An aggressive progression of IMT intensity to ensure a training overload has been stated 
essential for optimal adaption of exercise performance in healthy subjects [65], and similar to 
how IMT was used in some of the previous published EILO cases [147-149], with patients 
followed by numerous visits with adjustments of resistance related to Pimax. In our study, 
adjustment of resistance half-way through the treatment period of six-weeks was not 
performed in all, perhaps a weakness of the study, as a progression of training intensity might 
have improved the results. The initial response after IMT was seemingly unrelated to 
symptom scores 4-6 years later in Study #IV, perhaps not unexpected, as muscle strength is 
reversible and changes over time [163], a potential improvement after IMT may also be 
transitory. The same phenomenon is also observed in healthy subjects after IMT [218]. 
To conclude on these issues, our findings are, with the uncertainties listed, a small step in 
moving forward in the field of conservative treatment of EILO. We were unable to fully test 
the opportunities that lie within inspiratory muscle training (IMT) and EILO regarding 
different resistances, training protocols, repeated interventions etc. We need targeted 
prospective controlled trials to address the issue of IMST versus IMET modality, the 
application of laryngoscopy during IMT instructions and to what extent scheduling repeated 
supervised training sessions might contribute to better results.  
6.3.3 Supraglottoplasty on supraglottic EILO 
 
Our findings are consistent with other reports [137, 152, 154, 155]; supraglottoplasty as 
treatment for severe supraglottic EILO show positive results on both perceived symptoms and 
laryngeal obstruction during exercise. The level of self-reported symptoms seemingly 
corresponded with the degree of laryngeal obstruction. One study by Maat and colleagues also 
demonstrated lasting results of both laryngeal obstruction and symptoms [152]. 
Surgical technique 
 
Experience of the surgeons is an important factor for a successful outcome. The two senior 
consultants that performed the procedures in Study #III have experience with EILO patients 
and are familiar with micro-laryngeal surgery and the technique that was originally developed 
to treat severe congenital laryngomalacia, and they probably possess at least the same 
experience as the surgeons performing the procedure in other reports. However, this specific 
procedure has been performed in less than a hundred EILO patients at our hospital and only 
133 cases are published internationally to date (Table 3). We found no difference in outcomes 
between the two surgeons. Some have argued that endoscopic supraglottoplasty should be 
performed in two phases to avoid supraglottic stenosis [10], however, our findings indicate 
that it is safe to perform the procedure in one operation. Moreover, one operation also reduces 
the risk of anaesthetic complications.  
Diversity of laryngeal findings was also seen in the supraglottic EILO group with a variety of 
ways the supraglottic structures might adduct or close, suggesting a potential for different 
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surgical approaches. Despite this, the same procedure was performed in all, except for 
epiglottotomy or epiglottopexy performed additionally in five patients with epiglottic 
involvement. The contribution of epiglottis in hampering the airflow during exercise has not 
been established [25], hence the effect of epiglottopexy or epiglottotomy is neither 
established. Thorough retrospective assessment of the post-operative CLE-test files in Study 
#III, suggest that in some cases, more of the redundant supraglottic tissue could have been 
removed. But as stated, a careful approach should be undertaken when performing surgery on 
otherwise healthy young people. Future controlled studies ought to evaluate different surgical 




The diversity of findings in Study #III substantiates the complexity of the larynx and EILO. 
By nature, most improvement after supraglottoplasty was observed at the supraglottic level, as 
this is the level of intervention. Glottic closure has previously been stated to be unresponsive 
to surgical treatment [138], a notion which our findings challenge. An interesting finding in 
Study #III was the resolution/improvement also of glottic obstruction that correlated with 
reduced supraglottic obstruction, a finding observed in half the patients after 
supraglottoplasty. This phenomenon was also reported by Maat and colleagues [152], and the 
finding cannot easily be explained. One may speculate that the removal of redundant 
supraglottic tissue leads to a wider supraglottic opening, which might lead to less turbulent 
airflow during high volume ventilation induced by the exercise, and thereby prevent/reduce 
adduction of the vocal folds (the Bernoulli principle). Another contributing factor may be that 
the arytenoid cartilages may be less exposed to medializing powers after the surgery. A 
recently published article presenting findings in 19 EILO patients operated with 
supraglottoplasty, reported that one patient had developed more pronounced glottic 
obstruction postoperatively, [137], for which we have no good explanation. Glottic 
improvement after supraglottoplasty could perhaps also be present in other studies, but due to 
low rate of postoperative endoscopic evaluation this effect may have been missed.  
Relation to laryngomalacia 
 
In order to avoid a mix between the adult type of laryngomalacia and EILO in Study #III, we 
retrospectively chose to exclude four patients who had characteristics of laryngomalacia at 
rest [61]. One may discuss if this was correct, as there was also a large heterogeneity of 
structural laryngeal findings observed in the included EILO patients; however, judged to be 
within normal limits. To what extent the anatomical characteristics of laryngomalacia 
influence laryngeal function during exercise has not been established [8, 61]. When this is 
said, although the diagnosis of laryngomalacia had not been acknowledged before showing up 
in our study, the four excluded patients were younger (mean age 8.8), had two anatomical 
characteristics of laryngomalacia (omega-shaped epiglottis and redundant aryepiglottic folds), 
and their symptoms had started at an early age. They all showed reduced CLE-scores and 
reported improvement in symptoms after surgery. Since it is clearly stated in the 
ERS/ELS/ACCP taxonomy that a diagnosis of ILO requires that the larynx appears normal 
unless exposed to the inducer, we found that the exclusion of this subgroup was correct. 
Probably there is a gradual transition of laryngeal characteristics from laryngomalacia to 
“normal laryngeal findings”.  
6.3.4 Side-effects of treatment 
 
Cost-benefit analysis is necessary to perform for all treatment modalities [222]. Patients with 
EILO are otherwise healthy young people, with symptoms appearing only during exercise and 
any risks for complications should therefore be minimal. The term “safe” in Study #III was 
chosen to capture possible complications or adverse events after surgical interventions as this 
reflects the patient’s safety. 
IMT side-effects 
 
Two patients in Study #II with supraglottic EILO worsened their supraglottic obstruction after 
IMT, and this can in the future perhaps be avoided with proper patient selection, avoiding 
patients with clearly redundant supraglottic tissue. None reported long-term side effects after 
IMT in Study #IV and none of the previously published case-reports on IMT and EILO 
reported any side-effects. A need for repeated training periods may be perceived as a strain 
and needs to be addressed properly in future studies. IMT is perceived as a “safe” treatment 





Follow-up of laryngeal function after supraglottoplasty performed in EILO patients has only 
been reported up to five years [181]. Despite the procedure being performed in multiple 
centres all over the world, only a total of 72 cases were published prior to Study #III [181, 
182]. All studies report favourable results, with only two symptomatic complaints after 
surgery; one with dysphagia [154] and one with breathing difficulties while exercising in cold 
air [152], not provoked during the CLE-test in a laboratory setting. The procedure is based on 
the method performed in congenital laryngomalacia and has some established elements of 
risk, such as supraglottic stenosis and interarytenoid adhesion [223]. The experience of the 
surgeon and the choice of surgical technique (cold surgical techniques versus carbon dioxide 
laser) probably influences the risk of complications [137].  
Study #III is the first to report on complications based on endoscopic examination in all after 
the procedure; with one patient exhibiting a self-limiting vocal fold paresis and one patient 
who had developed scarring. Voice or swallowing complications as side-effects did not occur. 
Even though the procedure is generally considered safe, our reports of complications calls for 
caution when treatment management are decided. Conservative treatment options should be 
tested beforehand. Nor should we ignore the possibility that low reporting of complications 
may be due to publication bias or to the few postoperatively CLE-tests that have been 
performed. This emphasizes the importance of evaluation of the postoperative larynx during 
exercise, compare to pre-operative findings, and correlate laryngeal findings to the 
individual’s symptoms. 
 
6.3.5 Symptoms of EILO over time (Study #IV) 
  
There is a lack of longitudinal EILO studies in the literature. To be assigned a correct 
diagnosis, reassurance and simply to provide IBA has been reported to be sufficient to obtain 
control over EILO symptoms in most patients [6, 14, 79, 159], but whether this symptom 
control is sustained over time is unknown. We found in Study #IV that self-reported 
symptoms after 4-6 years improved compared to at diagnosis irrespective of additional six 
weeks of IMT at time of diagnosis. However, full symptom resolution after 4-6 years was 
rare, and respiratory problems still disturbed most participants during physical activity. We 
found no evidence that the perceived breathing problem from EILO had resolved simply 
because the patients had reached adulthood, and this was consistent with the few other reports 
[152, 155, 224]. One may speculate if the low response rates might possibly be related to the 
benign nature of the condition, and that symptoms of EILO only appear during exercise which 
(regrettably) seems to be an activity most people reduce as they grow older, irrespective of 
their laryngeal response patterns. Further, it might be that individuals who still perceived their 
breathing during exercise to be problem were more likely to respond, as previously alluded to. 
However, one study re-examining EILO patients with a CLE-test after 20 years of age, 
observed unchanged laryngeal findings paralleled by declining physical activity and symptom 
severity over time [152]. Studies of older patients (over the age of 20 years) [137], support the 
notion that growth does not resolve EILO, and that improved symptoms might instead be due 
to reduced physical activity with age (lower ventilation requirements) and/or better coping 
with symptoms.  
The improvements of self-reported symptoms after 4-6 years contribute to a positive view on 
these conservative treatment tools, particularly as regards glottic EILO. Answers from the 
IBA-group in Study #IV gives the impression that IBA might be sufficient in reducing 
symptoms over time in many with mild to moderate degree of laryngeal obstruction. The 
reported improvement after 4-6 years was unrelated to the findings shortly after IMT. Thus, 
the severity of diagnostic CLE-scores seemingly do not predict who will respond to IMT nor 
who will report high symptom scores after 4-6 years. We found an interesting tendency for 
less fear and possibly better symptom control in the IBA+IMT-group at follow-up, for which 




Answer to research questions 
 
Research question #1: Endoscopy provided visual confirmation of the relationship between 
the diaphragm and the PCA-muscle by visualization of laryngeal abduction during IMT in 
healthy subjects. 
Research question #2 and #3: Both IMST and IMET increased the laryngeal aperture in the 
investigated healthy subjects, but the application of medium resistance (IMET) appeared 
superior to higher resistance (IMST) to achieve the desirable abductive response in all.  
Research question #4: Self-reported exercise induced symptoms improved after six-weeks of 
IMT in selected EILO patients.  
Research question #5: The laryngeal obstruction during exercise (evaluated by CLE-score) 
improved after six-weeks of IMT in selected EILO patients. The improvements were seen 
mainly at the glottic level. 
Research question #6: Supraglottoplasty appeared as a safe treatment for highly selected 
severe supraglottic EILO patients. 
Research question #7: Self-reported exercise induced symptoms improved after 
supraglottoplasty in the investigated EILO patients.  
Research question #8: The laryngeal obstruction during exercise (evaluated by CLE-score) 
improved after supraglottoplasty in the investigated supraglottic EILO patients. 
Research question #9: Self-reported exercise symptoms and laryngeal outcomes in EILO 
improved shortly after IBA plus IMT in selected EILO patients.  
Research question #10: Self-reported exercise symptoms after 4-6 years was improved to 




This thesis has demonstrated that self-reported symptoms and laryngeal obstruction as 
observed and rated in CLE-tests, can improve after IMT or supraglottoplasty used to treat 
EILO patients.  
Our findings substantiate the heterogeneity of laryngeal response patterns, in both 
asymptomatic volunteers and EILO patients. It is unlikely that one treatment will work in all, 
and the findings suggest proper subgrouping of EILO, individual treatment and follow-up. 
Future controlled studies are needed, and this work provides hypotheses and data such studies 







We propose that future clinical trials should address the hypothesis that EILO consists of 
different subgroups by stratifying the population under study at least according to glottic and 
supraglottic EILO. We need validated instruments with established intra-subject and inter-
subject reliability to record self-reported perceived symptoms and grading of the laryngeal 
obstruction during CLE-tests. We need tools to establish the absolute dimensions of the 
laryngeal aperture, and the technique of measuring trans-laryngeal resistance might provide a 
future tool for better insight on the sequence of events and the absolute size of obstruction. 
This technique may serve as a functional objective continuous numerical measure of 
obstruction that can be compared to patients’ symptom descriptions. Pressure measurements 
might also serve as a more objective outcome measure of laryngeal obstruction in future 
intervention studies.  
Longitudinal studies after treatment with evaluation of the laryngeal obstruction are warranted 
in the future to evaluate development of EILO and possibly suggest who may need additional 
treatment to maintain physical activity.  
8.1.1 The role of IMT in the future 
 
 Lower resistances seem better than higher resistances, and endurance training better 
than high resistance (Pimax) training. We suggest prospective controlled studies to 
investigate IMST vs. IMET (Study #I). 
 We propose that IMT should be provided to EILO patients with mainly glottic 
obstruction or supraglottic EILO of only a mild degree (Study #II and #IV).  
 If a patient reports worsening of symptoms after IMT, the training should cease, and a 
new evaluation of laryngeal obstruction is warranted (Study #II).  
 We propose a randomized controlled trial to investigate the effects of simply 
providing IBA vs. additional treatment with IMT (Study #I and #IV).  
 We propose that IMT instructions preferably should be performed with a laryngoscope 
in place to ensure the element of biofeedback and to ensure adequate engagement of 
muscles (Study #I).  
 Adjustment of resistance during the intervention period is advised, and this should be 
tested in the future (Study #II and #IV). 
 Repeated IMT periods can be a possible strategy if symptoms reoccur and should be 
tested in the future (Study #IV). 
8.1.2 The role of supraglottoplasty in the future  
 
Based on experience from Study #III: 
 Properly controlled studies testing conservative treatment should be conducted before 
(and perhaps after) supraglottoplasty. 
 We propose that surgery should only be offered patients with severe supraglottic 
obstruction, but glottic involvement may not be an exclusion criterion in cases were 
glottic involvement appears as a secondary phenomenon and to a less extent.  
 After proper patient selection, controlled studies on supraglottoplasty and some sort of 
placebo surgery (or less extensive surgical procedures) should be conducted to try to 
reduce potential bias in our findings.  
 We propose future testing of minimal invasive surgical procedures guided by the 
laryngeal response during exercise to reduce the invasiveness and risk of 
complications. 
 Studies should be conducted to enhance the understanding of the role of the epiglottis 
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10. Appendix 1: Historical overview 
Historical overview-EILO  
1842 Dunglison:  the first description of “hysteric croup” in a medical textbook [225] 
1869 Mackinzie: the first visualization of abnormal movement of the vocal cords by 
laryngoscopy  
1902 Osler: Spasms of the laryngeal muscles during inspiration [226] 
1974 Patterson: “Munchausen stridor” as description of a woman with inspiratory stridor [84] 
1982 Dowing: Changes in respiratory movements of the human vocal cords during hyperpnea  
1983 Christopher: The true diagnosis of VCD/glottic obstruction, five patients with 
“uncontrolled asthma” [5] 
1984 Lakin:  Exercise first recognized as a cause of VCD and first description of a solely 
supraglottic cause of the laryngeal obstruction visualized by laryngoscopy 
after exercise [7] 
1994 Bittleman: First endoscopic examination with exercise, the laryngoscopy after exercise 
revealed abnormal motion of the arytenoid region in one case [9] 
1995 Smith: CLE-test on bicycle in one patient with “adult onset laryngomalacia”, first 
report on supraglottoplasty [81] 
1996 McFadden: 7 elite athletes with “chocking” sensation during exercise based on 
laryngoscopy or postexercise flow-volume loops [26] 
1996 Landwehr: 7 athletes with VCD based on postexercise inspiratory FVL flattening [87] 
1996 Bent: Stationary bicycle during exercise [8] 
1997 Pino: CLE-test in one patient with “intermittent symmetric arytenoid motion” [227] 
1999 Beaty: Laryngoscopy during exercise on healthy subjects for evaluation of normal 
laryngeal function during exercise [42] 
2006 Heimdal: Continuous laryngoscopy exercise-test on a treadmill, the CLE-test, four 
patients [3] 
2010 Christopher: Periodic occurrence of laryngeal obstruction (POLO) divided into three 
categories: psychogenic, exertional and irritant (intrinsic and extrinsic) [4] 
  
Overview of treatment of EILO before the included studies of this thesis  
1995 Smith: First report on supraglottoplasty in one patient with “adult onset 
laryngomalacia” [81]. 
1996 Bent: Two patients with supraglottic EILO treated with supraglottoplasty [8]. 
2000 Archer: Inspiratory muscle training (IMT) from an anaesthetic equipment used to treat 
symptoms of vocal cord dysfunction (VCD) at rest [171]. 
2000 Bjørnsdatter:  Two patients with supraglottic EILO treated with supraglottoplasty [54]. 
2000 Altman:  Report on 10 patients with ILO at rest, were five were treated with botulinum 
toxin and 2 with flexible nasopharyngoscopy biofeedback [228] 
2001 Sullivan: Report of 20 female athletes with EILO treated with speech therapy [140]. 
2002 Chemery: One patient with supraglottic EILO treated with supraglottoplasty [178]. 
2002 Newsham: Description of a therapeutic exercise program designed to promote 
diaphragmatic breathing in athletes with EILO, reported to “have been used 
successfully with collegiate and high school athletes and has been 
administered in both chronic and acute settings by speech-language 
pathologists and certified athletic trainers” [157]. 
2003 Mandell:  One patient with supraglottic EILO treated with supraglottoplasty [10]. 
2004 Ruddy: First report on an athlete (rower) with EILO treated with IMT [148]. 
2005 Mathers-Schmidt: An athlete with EILO treated with IMT for 5 weeks “on-off” for a total of 16 
weeks, and one session of “patient education and relaxed-throat technique” 
[147]. 
2006 Doshi: First report on use of Ipratropium Bromide inhaler before exercise to treat 
EILO [144]. 
2007 Dickinson: An athlete with inspiratory stridor treated with IMT for 11 weeks [149]. 
2007 Maat: Ten patients with supraglottic EILO treated with supraglottoplasty [153].  
2008 Ritcher: Three patients with supraglottic EILO treated with supraglottoplasty. 
2010 McNally: One patient with supraglottic EILO treated with supraglottoplasty. 
2011 Maat: Twenty-three (10 of them previously reported) patients with supraglottic EILO 
treated with supraglottoplasty and follow-up after 2-5 years, compared to 14 
conservatively treated (with information and breathing advice) patients [152].  
2012 Dion:  Three patients with supraglottic EILO treated with supraglottoplasty [41]. 
2013 Chiang:  Laryngeal control therapy in patients with paradoxical vocal fold movement 




11. Appendix 2: Questionnaires 
SPØRRESKJEMA FOR FØRSTE CLE-TEST 
 Dato•  EILS nr•  
1. SYKEHISTORIE 
1.1 Falsk krupp episoder som liten? 
 □ Ofte (>10 ganger)     □ Av og til (4-10 ganger) □  Sjeldent (0-3 ganger) □  Aldri hatt 
 
 1.2  Operert mandler/falske mandler?   
             □ JA                      □ NEI 
1.3 Operasjoner i svelg eller strupe? 
 □  JA □ NEI 
1.4  Operasjoner i nese-bihuler? 
 □ JA □  NEI 
1.5   Dren i ører som barn? 
□  JA                 □ NEI 
1.6    Unormal lyd i pusten som spedbarn? 
 
 □  JA □ NEI □ VET IKKE 
 
1.7 Hvor mange nedre luftveisinfeksjoner (bronkitt/lungebetennelse) har du hatt totalt? 
 Ofte (>10 ganger) □ Av og til (4-10 ganger)  □ Sjeldent (0-3 ganger) □  Aldri hatt 
1.8 Hvor mange øvre luftveisinfeksjoner (forkjølelser) har du hatt siste 12 mnd? 
 
 □ Ofte (>10 ganger)  □ Av og til (4-10 ganger) □  Sjeldent (0-3 ganger) 
1.9 Hvor ofte har du vært hes de siste 12 mnd? 
  □ Aldri hatt 
 □ Ofte (>10 ganger) □ Av og til (4-10 ganger)  □ Sjeldent (0-3 ganger) 
1.10 Hvor ofte har du vært plaget med nesetetthet de siste 12 mnd? 
  □ Aldri hatt 
□  Ofte (>10 ganger) □  Av og til (4-10 ganger) □  Sjeldent (0-3 ganger) 
1.11 Er du plaget med halsbrann/sure oppstøt (gastroøsofagalrefluks)? 
  □ Aldri hatt 
  □ JA  □ NEI 
Hvis JA: 
           1.11.1 Har du fått påvist såkalt gastroøsofagal refluks? 
   
□JA  NEI 
 1.11.2 Er du under utredning for halsbrann/sure oppstøt?                □ JA                 □ NEI 
 
2. ASTMA 
2.1 Har du diagnosen astma (dvs. astmasymptomer utenom anstrengelse)? 
 
 □  JA □  NEI □ USIKKERT 
2.1.1 Hvis ja, hvor gammel var du da du fikk diagnosen? 
 
2.3 Har du diagnosen anstrengelsesutsløst astma? 
  □ JA □  NEI □ USIKKERT 
2.4 Har du brukt astmamedisiner? 
  □ JA □ NEI 
2.5.1 Hvilke astmamedisiner har du brukt?  
 
 
2.5.2 Bruker du astmamedisiner nå (ca. de siste 2-3 månedene)? 
 
 □ JA □ NEI 
2.5.3 Hvilke astmamedisiner bruker du nå? 
 
 
2.5.4 Bruker du astmamedisin ved trening? 
  □ JA □ NEI 
2.5.5 Bruker du astmamedisin utenom trening? 
 □ JA □ NEI 




 □  LITE/INGEN BEDRING □  NOE BEDRING □  STOR BEDRING 
 
2.6 Hvor ofte har du hatt astmaanfall siste 12 mnd? 
  □ INGEN □ 1-3 GANGER □ 4-12 GANGER □  > 12 GANGER 
3. HAR DU ANDRE SYKDOMMER/DIAGNOSER? 
 
 
4. BRUKER DU ANDRE MEDISINER? 
 
5. ANSTRENGELSE UTLØST PUSTEBESVÆR 
5.1 Hvor gammel var du da pusteprobtemer ved anstrengelse startet? år  
 




5.3 I hvilke situasjoner opplever du pusteproblemer? 
□ I hvile 
□ Ved lett anstrengelse (gange) 
□  Ved moderat anstrengelse/trening (eks. jogging)   
□  Ved kraftig anstrengelse (hard trening / konkurranse) 
5.4 Er det noe som gjør at du lettere får slike pusteproblemer? 
□  Sigarettrøyk □  Røykos □  Sterke lukter □  Psykisk belastning/stress □  Kulde  
□ Fuktig/rått vær (tåke)  □ Varme (Syden) □  Nesetetthet □  Annet: 
 
5.5 Er det spesielle typer aktiviteter/treningsformer som lettere gir deg pusteproblemer? 
 
5.6 Hvordan vil du beskrive problemet ditt? Hvor riktige er disse utsagnene for deg? 
1=Aldri 2=Noen ganger 3=0fte 4=Nesten alltid 5=Hver gang 
5.6.1. Jeg har problemer med innpust                                    1 2 3 4 5 
5.6.2 Jeg har problemer med utpust 1 2 3 4 5 
5.6.3. Jeg føler tetthet/smerte i hals 1 2 3 4 5 
5.6.4 Jeg føler tetthet/smerte i bryst 1 2 3 4 5 
5.6.5. Jeg får hes stemme 1 2 3 4 5 
5.6.6. Jeg må stadig harke og kremte 1 2 3 4 5 
5.6.7. Jeg har følelse av å bli kvalt 1 2 3 4 5 
5.6.8. Jeg blir svimmel/kvalm og føler jeg besvimer 1 2 3 4 5 
5.6.9. Problemet kommer raskt                                                 1 2 3 4 5 
5.6.10. Problemet går fort over 1 2 3 4 5 
5.6.1 1. Jeg får følelse av panikk 1 2 3 4 5 
5.6.12  Jeg får pustevansker når jeg er i fysisk aktivitet       1           2           3           4           5 
5.6.13. Jeg hører unormal lyd/piping i pusten 1 2 3 4 5 
5.6.14. Pusteproblemene hindrer meg i å trene 1 2 3 4 5 
5.6.15. Jeg blir redd når pustevanskene opptrer I 2 3 4 5 
5.6.16. Jeg lar være å presse meg fysisk pga pustevanskene 1 2 3 4 5 
5.6.17. Pustevanskene fortsetter også etter at jeg stopper/hviler 12 3 4 5 
5.6.18. Jeg kan kontrollere pustevanskene når de kommer 1 2 3 4 5 
5.7 Hvordan påvirker problemet deg i hverdagen? 
 
1=Aldri 2=Noen ganger 3=0fte 4=Nesten alltid 5=Hver gang 
5.7.1 Jeg har problemer med å løpe opp 
 en trapp mellom to etasjer  2 3 4 5 
5.7.2 Jeg har problemer med mosjon/gymnastikk 1 2 3 4 5 
5.7.3 Jeg har problemer under lett trening 1 2 3 4 5 
5.7.4 Jeg har problemer under hard trening 
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 eller idrettskonkurranser 1 2 3 4 5 
5.7.5 Problemene er verre under konkurranser 
 enn ved tilsvarende hard trening 1 2 3 4 5 
5,8 Hvordan opplever du pusteproblemet? 
       5.8.1. Pustebesværet er likt fra gang til gang  □  JA  □ NEI 
       5.8.2 Pustevanskene kan være en psykisk belastning  □  JA  □ NEI  
       5.8.3. Pustevanskene hindrer meg i å oppnå det jeg vil  □  JA  □ NEI 
5.9 Dersom symptomene oppstår når du er fysisk aktiv, hvor lang tid tar det før 
pustevanskene forsvinner etter at du har stoppet aktiviteten. 
 □  0-5 min. □ 5-15 min                 □ 15-45 min. □ 45 min. eller mer 
5.10 Når du er fysisk aktiv, hvor mye er du plaget av dine pustevansker 
 □  Ikke noe □ Ganske mye □ Veldig mye □ Invalidiserende 
5.11 Totalt sett i livet ditt, hvor mye er du plaget av dine pustevansker 
  
 □  Ikke noe □ Ganske mye □ Veldig mye □ Invalidiserende.  
 
6. AKTIVITETSNIVÅ 
6.1 Hvor mange ganger i uken driver du med idrett, eller mosjonerer du så mye at du blir 
andpusten og/eller svett? 
 □  Hver dag    □  4-6 ganger i uken □  2-3 ganger i uken □  En gang i uken 
   
 □ En gang i mnd □  Mindre enn en gang i mnd         □   Aldri 
 
6.2 Hvor mange timer i uken driver du med idrett, eller mosjonerer du så mye at du blir 
andpusten og/eller svett? 
 □  Ingen □  omtrent 1/2 time □  omtrent 1 time  □ omtrent 2-3 timer 
 □  omtrent 4-6 timer  □ 7 timer eller mer 
 
6.3 Hvilken type idrett driver du med? 
 
6.3.1 På hvilket nivå? 
 □  Mosjon □ Lokallag □  Regionalt nivå □ Nasjonalt nivå 
□  Internasjonalt 
6.3.2 Har du trappet ned aktivitetsnivået ditt grunnet problemer? 
 
□  JA □  NEI 
6.3.3. Hvis Ja, på hvilken måte har du endret aktivitetsnivået? 
 □  Måtte slutte med idrett □  Måtte trappe ned på nivå □  Har skiftet type idrett 
 
6.4 Hvis jeg ikke hadde disse pusteproblemene, ville jeg vært mer fysisk aktiv 






FOLLOW-UP OF PATIENTS WITH EXERCISE-INDUCED  
RESPIRATORY SYMPTOMS 
 
Please answer all questions, and answer as to how you are feeling now.  
1. Which treatment did you receive? (Tick as many boxes as appropriate) 
¤ Information (about the condition) only 
¤ Inspiratory muscle training 
¤ Speech therapy 
¤ Surgery 
¤ Treatment at another clinic 
2.  How have your breathing problems changed since your first appointment (Q-A.1-8)? 
Q-A.1 The breathing problem have got worse     □ Yes □ No □ Unsure 
Q-A.2 Unchanged, they bother me about as much as before □ Yes □ No □ Unsure 
Q-A.3 Unchanged, but I have learnt to live with them  □ Yes □ No □ Unsure 
Q-A.4 They cause me less problems because I am less active □ Yes □ No □ Unsure 
Q-A.5 They cause me less problems because I avoid activities  
that provoke symptoms     □ Yes □ No □ Unsure 
Q-A.6 Symptoms are not as severe as before   □ Yes □ No □ Unsure 
Q-A.7 The breathing problem has improved    □ Yes □ No □ Unsure 
Q-A.8 I no longer have a breathing problem   □ Yes □ No □ Unsure 
 
 
3.1 Considering all aspects of life, how much did your breathing problems effect you before you 
received treatment (Q-B.1)? 
□ Not at all □ A little       □ Quite a lot   □ A great amount □ Crippling 
3.2  Considering all aspects of life, how much do your breathing problems effect you now (Q-B.2)? 
□ Not at all □ A little             □ Quite a lot                □ A great amount □ Crippling 
 
4.  How would you describe your breathing problems NOW (Q1-18)? 
 
Never Occasionally Often 
Nearly 
always Always 
Q.1.  I have problems breathing in 1 2 3 4 5 
Q.2. I have problems breathing out 1 2 3 4 5 
Q.3.  I feel tightness/pain in my throat 1 2 3 4 5 
Q.4.  I feel tightness/pain in my chest 1 2 3 4 5 
Q.5.  I get a hoarse voice   1 2 3 4 5 
Q.6.  I frequently have a cough/clear my throat 1 2 3 4 5 
Q.7.  I feel like I’m being choked 1 2 3 4 5 
Q.8.  I become dizzy, nauseous and feel like I’m 
going   to faint 
1 2 3 4 5 
Q.9.  The symptoms come on fast 1 2 3 4 5 
Q.10.  The symptoms quickly resolve   1 2 3 4 5 
Q.11.  I feel panic 1 2 3 4 5 
Q.12.  I have problems breathing when I am 
physically active 
1 2 3 4 5 
      
Q.13.  I can hear unusual or peeping sounds when 
I breathe   
1 2 3 4 5 
Q.14.  My symptoms prevent me from 
training/exercising 
1 2 3 4 5 
Q.15.  I become afraid when I get symptoms 1 2 3 4 5 
Q.16.  My symptoms prevent me pushing myself 
when exercising 
1 2 3 4 5 
Q.17.  My breathing problems continue even 
after I have stopped exercise/rested 
1 2 3 4 5 
Q.18.  I can control my symptoms when I get 
them 
1 2 3 4 5 
 
 
5.  How many hours per week do you play sport/ exercise at an intensity that makes you 
breathless and / or sweaty. 
□ None 
□ About 30 minutes  
□ About 1 hour 
□ About 2-3 hours  
□ About 4-6 hours   
□ 7 hours or more 
 
6.1 What sport do you play?________________________________________________ 
6.2  At what level?  
□ For personal training  





7. Have you experienced any side effects/ negative symptoms after treatment for your 
exercise induced breathing problems?      
□ no prolonged side effects / problems 
□ Yes 













Thank you for taking the time to answer! 
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